propranolol has been researched along with Abdominal Migraine in 354 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| " There was no clear difference regarding efficacy between flunarizine and betahistine in the vertigo study." | 7.69 | Postmarketing study of the use of flunarizine in vestibular vertigo and in migraine. ( Amery, WK; De Locht, P; Verspeelt, J, 1996) |
| "We report a case of migraine-associated ischemic stroke causing amnesia, wherein treatment with propranolol may have been contributory." | 7.69 | Migrainous stroke causing thalamic infarction and amnesia during treatment with propranolol. ( Greiner, F; Hamilton, WJ; Mendizabal, JE; Rothrock, JF, 1997) |
| "The authors report the onset of wheezing and dyspnea in a 32-year-old, nonasthmatic male who was receiving propranolol for chronic migraine headaches of 20 years' duration." | 7.66 | Propranolol-induced dyspnea in a nonasthmatic male. ( Araki, M; Clark, BG; Rawlings, JL, 1982) |
| " Propranolol and venlafaxine improved the Vertigo Symptom Scale score by -13." | 5.41 | A systematic review and meta-analysis of prophylactic medication of vestibular migraine. ( Hamilton, L; Kontorinis, G; Slim, M; Yiannakis, C, 2023) |
| "Propranolol's efficacy in reducing facial pain index was greater among the 104 migraineurs than the 95 non-migraineurs: For example, for the binary ≥ 30% reduction in facial pain index, odds ratios were 3." | 5.41 | Effect of comorbid migraine on propranolol efficacy for painful TMD in a randomized controlled trial. ( Arbes, SJ; Campbell, JH; Fillingim, RB; Giosia, MD; Hadgraft, H; Lim, PF; Ohrbach, R; Ribeiro-Dasilva, M; Slade, GD; Tchivileva, IE; Willis, J, 2021) |
| " On the other hand, patients with divalproex exhibited significantly higher risk of nausea compared to those with placebo, topiramate, propranolol, gabapentin and amitriptyline." | 4.95 | Unveiling the relative efficacy, safety and tolerability of prophylactic medications for migraine: pairwise and network-meta analysis. ( He, A; Li, C; Song, D; Zhang, L, 2017) |
| " There are four separate strands of evidence for this: the common co-existence of abdominal pain and migraine headaches; the similarity between children with episodic abdominal pain and children with migraine headaches, with respect to social and demographic factors, precipitating and relieving factors, and accompanying gastrointestinal, neurological and vasomotor features; the effectiveness of nonanalgesic migraine therapy (such as pizotifen, propanolol, cyproheptadine and the triptans) in abdominal migraine; and the finding of similar neurophysiological features in both migraine headache and abdominal migraine." | 4.81 | Abdominal migraine: evidence for existence and treatment options. ( Abu-Arafeh, I; Russell, G; Symon, DN, 2002) |
| " For the acute treatment of migraine attacks or tension-type headache, ibuprofen (10 mg per kg body weight) or acetaminophen (15 mg per kg body weight) are recommended with highest evidence, intranasal sumatriptan (10 to 20 mg) can be given as second choice." | 4.81 | [Treatment of idiopathic headache in childhood - recommendations of the German Migraine and Headache Society (DMKG)]. ( Evers, S; Gerber, WD; Naumann, E; Pothmann, R; Uberall, M, 2002) |
| "The aim of the present study was to determine the efficacy of propranolol treatment in patients with vestibular migraine by the Visual Analog Scale, Dizziness Handicap Inventory (DHI), Vertigo Symptom Scale, and Vestibular Disorders Activities of Daily Living Scale (VADL) and its effect on the quality of life." | 3.96 | The Effectiveness of Medical Prophylactic Treatment on Vestibular Migraine and Its Effect on the Quality Of Life. ( Çelik, O; Eskiizmir, G; İncesulu, A; Şahin Süyür, N; Tanyeri Toker, G, 2020) |
| " Results VL-102-evoked acute and chronic mechanical cephalic and hind-paw allodynia in a dose-dependent manner, which was blocked by the migraine medications sumatriptan, propranolol, and topiramate." | 3.88 | Soluble guanylyl cyclase is a critical regulator of migraine-associated pain. ( Ben Aissa, M; Bennett, BM; Bertels, Z; Gaisina, IN; Gandhi, R; Lee, SH; Litosh, V; Moye, LS; Novack, M; Pradhan, AA; Thatcher, GR; Tipton, AF; Wang, Y, 2018) |
| "Propranolol has been most extensively studied and proved effective in 19 of 21 controlled trials." | 3.77 | [Beta-blockers and migraine]. ( Bousser, MG; Massiou, H, 1992) |
| "The modal migraine sufferer treated in these studies was a female, about 37 years of age, who suffered from common (rather than classical) migraines and reported a 17-year history of problem migraines." | 3.77 | Propranolol in the management of recurrent migraine: a meta-analytic review. ( Cordingley, GE; Holroyd, KA; Penzien, DB, 1991) |
| "Trials of drugs in the prophylaxis of migraine have in general been unsatisfactory due to the difficulty in controlling many variables." | 3.75 | Beta-adrenoceptor blockade and migraine. ( Patel, L; Turner, P; Weerasuriya, K, 1982) |
| "Children aged 16 years or less with first diagnosed of either migraine or tension-type headache were reassured the cause of headache and treated by avoiding triggering factors, taking intermittent analgesics or a daily preventive medication such as propanolol 10 mg two times a day or amitriptyline 10 mg at night for patients who were suffered from the frequent headache attacks whether had to stop activity or go to sleep." | 3.74 | Short-term outcomes of tension type and migraine headache in children. ( Ruangsuwan, S; Sri-udomkajorn, S, 2008) |
| "Patients with abdominal migraine may benefit from prophylactic treatment with propranolol or cyproheptadine." | 3.70 | Abdominal migraine: prophylactic treatment and follow-up. ( Lichtman, SN; Rhoads, JM; Ulshen, MH; Worawattanakul, M, 1999) |
| " There was no clear difference regarding efficacy between flunarizine and betahistine in the vertigo study." | 3.69 | Postmarketing study of the use of flunarizine in vestibular vertigo and in migraine. ( Amery, WK; De Locht, P; Verspeelt, J, 1996) |
| "We report a case of migraine-associated ischemic stroke causing amnesia, wherein treatment with propranolol may have been contributory." | 3.69 | Migrainous stroke causing thalamic infarction and amnesia during treatment with propranolol. ( Greiner, F; Hamilton, WJ; Mendizabal, JE; Rothrock, JF, 1997) |
| "Ergotamine exposure during pregnancy has been suggested to cause birth defects which have a vascular disruptive aetiology." | 3.67 | Birth defects following maternal exposure to ergotamine, beta blockers, and caffeine. ( Goldstein, DA; Hughes, HE, 1988) |
| "The authors report the onset of wheezing and dyspnea in a 32-year-old, nonasthmatic male who was receiving propranolol for chronic migraine headaches of 20 years' duration." | 3.66 | Propranolol-induced dyspnea in a nonasthmatic male. ( Araki, M; Clark, BG; Rawlings, JL, 1982) |
| "Propranolol was found to be non-inferior and not superior to topiramate (point estimate of -1." | 3.11 | TOP-PRO study: A randomized double-blind controlled trial of topiramate versus propranolol for prevention of chronic migraine. ( Bansal, L; Chowdhury, D; Datta, D; Duggal, A; Gupta, A; Koul, A; Krishnan, A; Mundra, A, 2022) |
| " This study aimed to compare the effect of cinnarizine combination with propranolol and propranolol with placebo in preventing acute migraine attacks." | 3.11 | Comparison of the Effect of Propranolol Combination with Cinnarizine and Propranolol in the Prevention of Acute Migraine Attacks. ( Adeeb Sheet, D; Bibani, RH; Kheder, AH, 2022) |
| "Among people with episodic migraine, a broader number of blood pressure-lowering medication classes and drugs reduce headache frequency than those currently included in treatment guidelines." | 3.01 | The effect of blood pressure lowering medications on the prevention of episodic migraine: A systematic review and meta-analysis. ( Anderson, CS; Atkins, E; Bai, Y; Balicki, G; Carcel, C; Clough, AJ; Cordato, D; Davies, L; Delcourt, C; Griffiths, LR; Haghdoost, F; Malavera, A; Nanda, P; Rodgers, A; Shen, J; Torii-Yoshimura, T; Vidyasagar, K; Wang, X; Zagami, AS, 2023) |
| "Beta-blockers are effective for migraine attack prophylaxis but are associated with dizziness and fatigue and are contraindicated in patients with certain co-morbidities, including asthma, congestive heart failure, and abnormal cardiac rhythms." | 3.01 | Non-CGRP Antagonist/Non-Triptan Options for Migraine Disease Treatment: Clinical Considerations. ( Ahmadzadeh, S; Bocklud, BE; Corley, SC; Granier, MA; Ingram, EE; Kaye, AD; Neuchat, EE; Shekoohi, S, 2023) |
| "However, in contrast to ordinary migraine, vestibular migraine patients have distinct characteristics, and the detailed treatment strategy for vestibular migraine is different and more challenging than ordinary migraine treatment." | 3.01 | Network Meta-analysis of Different Treatments for Vestibular Migraine. ( Chen, JJ; Chen, TY; Chen, YW; Hsu, CW; Stubbs, B; Su, KP; Tseng, PT; Tu, YK; Wu, YC; Zeng, BS; Zeng, BY, 2023) |
| "Migraine is a common form of headache that affects patients quality of life negatively." | 2.84 | Effect of Prayer on Intensity of Migraine Headache: A Randomized Clinical Trial. ( Divsalar, K; Esmaili, Z; Rafiei, H; Safizadeh, H; Tajadini, H; Zangiabadi, N, 2017) |
| "Cinnarizine has demonstrated encouraging potential in preventing the attacks of migraine." | 2.82 | Application of cinnarizine in migraine prevention: A systematic review and meta-analysis. ( Akbari, Z; Ardestani, PM; Gholampour, M; Kouhanjani, MF; Nemati, H; Sarvipour, N; Shafie'ei, M; Shekouh, D, 2022) |
| "Thirty percent of children with severe migraine attacks have school absence and reduced quality of life that need preventive therapy." | 2.80 | Comparison of propranolol and pregabalin for prophylaxis of childhood migraine: a randomised controlled trial. ( Bakhshandeh Bali, M; Ghofrani, M; Karimzadeh, P; Rahbarimanesh, AA; Sadeghi, M; Sedighi, M, 2015) |
| "Candesartan was non-inferior to propranolol (and vice versa)." | 2.79 | A comparative study of candesartan versus propranolol for migraine prophylaxis: A randomised, triple-blind, placebo-controlled, double cross-over study. ( Aamodt, AH; Gravdahl, GB; Hagen, K; Linde, M; Sand, T; Stovner, LJ; Tronvik, E, 2014) |
| "Sixty patients with migraine were selected and enrolled in a 12-week double-blind controlled clinical trial to evaluate the efficacy of subcutaneous administration of N-alpha methyl histamine (1 to 3 ug twice a week ) n=30, compared to administration of 120 mg/day of oral propranolol n=30." | 2.79 | N alpha methyl histamine versus propranolol in migraine prophylaxis. ( Castillo-Varela, G; Guzmán-Chávez, B; Isais-Millán, R; Millán-Guerrero, RO, 2014) |
| "Pediatric Migraine Disability Assessment score reduced from 31." | 2.78 | Topiramate and propranolol for prophylaxis of migraine. ( Divanizadeh, MS; Fallah, R; Karimi, M; Mirouliaei, M; Shamszadeh, A, 2013) |
| "The propranolol and SS group was significantly superior to the other groups on all other headache endpoints and in disability, in both ITT and PP analyses." | 2.78 | Treatment of comorbid migraine and temporomandibular disorders: a factorial, double-blind, randomized, placebo-controlled study. ( Bigal, ME; Camparis, CM; Castanharo, SM; Goncalves, DA; Lipton, RB; Speciali, JG; Ujikawa, LT, 2013) |
| " No significant adverse effects were reported." | 2.77 | Efficacy and safety of cinnarizine in the prophylaxis of migraine headaches in children: an open, randomized comparative trial with propranolol. ( Asa, S; Ashrafi, MR; Mahvelati, F; Malamiri, RA; Rashidi-Ranjbar, N; Togha, M, 2012) |
| "Propranolol is effective for migraine prophylaxis." | 2.76 | The effect of propranolol on cerebrovascular reactivity to visual stimulation in migraine. ( Kwon, HM; Min, JH; Nam, H, 2011) |
| "The propranolol dosage was adjusted to 2 mg/kg/day and the sodium valproate dosage to 15 mg/kg/day, after the first follow-up visit." | 2.75 | A randomized trial of propranolol versus sodium valproate for the prophylaxis of migraine in pediatric patients. ( Bidabadi, E; Mashouf, M, 2010) |
| "Frequent migraine sufferers who failed to respond to 5 weeks of optimized acute migraine drug therapy were randomized to a 2 (Behavioral Migraine Management+, Behavioral Migraine Management-) × 2 (β-blocker, placebo) treatment design." | 2.75 | Dynamics of changes in self-efficacy and locus of control expectancies in the behavioral and drug treatment of severe migraine. ( Holroyd, KA; Seng, EK, 2010) |
| "To evaluate the effect of different migraine prophylaxis medications on subject responsiveness to almotriptan." | 2.74 | Variation in almotriptan effectiveness according to different prophylactic treatments. ( Bermejo, PE; Dorado, R; Gomez-Arguelles, JM, 2009) |
| "For treatment and control of the migraine, in patients with normal encephalogram, propranolol with tricyclic antidepressive drugs advised and for abnormal encephalogram sodium valprovate can be the better treatment for management and reduction of headache attacks." | 2.74 | Comparison of treatment effect of sodium valproate, propranolol and tricyclic antidepressants in migraine. ( Abolfazl, MB; Keyvan, G, 2009) |
| "Treatment with nortriptyline alone was not effective." | 2.74 | A double-blind randomized controlled trial of low doses of propranolol, nortriptyline, and the combination of propranolol and nortriptyline for the preventive treatment of migraine. ( Aquino, CC; Domingues, RB; Domingues, SA; Kuster, GW; Silva, AL, 2009) |
| "Topiramate (TPM) has shown efficacy in migraine prophylaxis in two large placebo-controlled, dose-ranging trials." | 2.71 | Topiramate in migraine prophylaxis--results from a placebo-controlled trial with propranolol as an active control. ( Dahlöf, C; Diener, HC; Doyle, A; Jacobs, D; Láinez, MJ; Neto, W; Sandrini, G; Tfelt-Hansen, P; Vijapurkar, U; Wang, SJ, 2004) |
| "Treatment with propranolol showed a trend towards improvement compared with the run-in period." | 2.71 | Effect of low-intensity acenocoumarol on frequency and severity of migraine attacks. ( Egberts, AC; Lenderink, AW; Smidt, MH; Tijssen, CC; van't Hoff, AR; Wammes-van der Heijden, EA, 2005) |
| " Treatment effects on pharmacokinetic parameters were assessed by analysis of variance (ANOVA)." | 2.70 | Lack of pharmacokinetic interaction between the antimigraine compound, almotriptan, and propranolol in healthy volunteers. ( Azie, NE; Carel, BJ; Fleishaker, JC; Sisson, TA, 2001) |
| "Cyclandelate, however, was superior to placebo in a global impression of efficacy rated by the patients and the treating physicians." | 2.70 | Cyclandelate in the prophylaxis of migraine: a placebo-controlled study. ( Diener, HC; Freytag, S; Krupp, P; Milde, K; Schmitt, T; Steitz, G, 2001) |
| "Forty migraineurs (10 males, 30 females) were randomized according to a two-period (3-month), two-treatment, crossover design." | 2.70 | Alpha-dihydroergocryptine and predictive factors in migraine prophylaxis. ( Ambrosoli, L; Cavallini, A; Mailland, F; Marcheselli, S; Micieli, G; Nappi, G, 2001) |
| "Both flunarizine groups were at least as effective as propranolol (P<0." | 2.70 | Efficacy and tolerability in migraine prophylaxis of flunarizine in reduced doses: a comparison with propranolol 160 mg daily. ( De Beukelaar, F; Diener, HC; Hartung, E; Ludin, HP; Matias-Guiu, J; Nappi, G; Pfaffenrath, V, 2002) |
| "Forty-two patients with migraine without aura underwent the test before and 2 months after antimigraine therapy." | 2.69 | Long-term outcome of migraine therapy: predictive value of the frontotemporal nitroglycerin test. ( Amato, D; Bonuso, S; Caruso, G; de Angelis, S; Di Stasio, E; Marano, E; Scellini, T, 1998) |
| " Thirty-three patients were randomized to relaxation-biofeedback training alone (administered in a limited-contact treatment format), or to relaxation-biofeedback training accompanied by long-acting propranolol (with dosage individualized at 60, 120, or 180 mg/day)." | 2.68 | Enhancing the effectiveness of relaxation-thermal biofeedback training with propranolol hydrochloride. ( Cordingley, GE; France, JL; Holroyd, KA; Kvaal, SA; Lipchik, GL; McCool, HR; Rokicki, LA, 1995) |
| "The impact of short-term treatment for migraine attacks on these variables was evaluated in an open prospective 6-month study at the Gothenburg Migraine Clinic." | 2.68 | Health-related quality of life under six months' treatment of migraine--an open clinic-based longitudinal study. ( Dahlöf, CG, 1995) |
| "Propranolol was somewhat better than flunarizine in reducing the severity of migraine attacks, although this may have been due to a selection bias." | 2.68 | Post-marketing cohort study comparing the safety and efficacy of flunarizine and propranolol in the prophylaxis of migraine. ( Amery, WK; De Locht, P; Verspeelt, J, 1996) |
| "The number of migraine attacks (> or = 50% responders) and the migraine duration/month were compared based on the difference between baseline and the last 4 weeks of prophylactic treatment." | 2.68 | Cyclandelate in the prophylaxis of migraine: a randomized, parallel, double-blind study in comparison with placebo and propranolol. The Study group. ( Diener, HC; Fischer, M; Föh, M; Iaccarino, C; Isler, H; Strenge, H; Taneri, Z; Wedekind, W; Wessely, P, 1996) |
| "Propranolol was titrated to 180 mg/d in 28 patients, to 240 mg/d in 1, and downward in 3." | 2.68 | A comparison of divalproex with propranolol and placebo for the prophylaxis of migraine without aura. ( Kaniecki, RG, 1997) |
| "Both drugs significantly reduced migraine attacks as judged from the reduction in the efficacy parameters (migraine hours, migraine days, and migraine intensity) in the treatment periods compared with the run-in period." | 2.67 | Tolfenamic acid versus propranolol in the prophylactic treatment of migraine. ( Borg, L; Hansen, PE; Holt Larsen, B; Kjaersgård Rasmussen, MJ; Soelberg Sørensen, P, 1994) |
| "Amitriptyline response was correlated with female gender and baseline headaches of shortest duration and of highest frequency." | 2.67 | Propranolol and amitriptyline in prophylaxis of migraine. Pharmacokinetic and therapeutic effects. ( Hassanein, R; Hurwitz, A; Preskorn, S; Seim, J; Ziegler, DK, 1993) |
| "A minimum of three migraine attacks were treated during each treatment period." | 2.67 | Propranolol in the treatment of acute migraine attacks. ( Banerjee, M; Findley, L, 1991) |
| "Nifedipine was of no value in the prophylaxis of migraine." | 2.67 | Responders and non-responders to metoprolol, propranolol and nifedipine treatment in migraine prophylaxis: a dose-range study based on time-series analysis. ( Diener, HC; Gerber, WD; Niederberger, U; Scholz, E, 1991) |
| "A reduction in the number of migraine attacks was observed in 75% of the flunarizine group and in 73." | 2.67 | [The treatment of juvenile migraine using flunarizine or propranolol]. ( Lütschg, J; Vassella, F, 1990) |
| "Propranolol is an established agent in migraine prophylaxis." | 2.67 | Propranolol in acute migraine: a controlled study. ( Fuller, GN; Guiloff, RJ, 1990) |
| "The primary outcome was migraine episodes." | 2.66 | Acupuncture versus propranolol in migraine prophylaxis: an indirect treatment comparison meta-analysis. ( Chen, M; Chen, YY; Li, J; She, TW; Yue, L; Zheng, H, 2020) |
| "Primary outcomes were efficacy (ie, migraine frequency, number of migraine days, number of headache days, headache frequency, or headache index), safety (ie, treatment discontinuation owing to adverse events), and acceptability (ie, treatment discontinuation for any reason)." | 2.66 | Efficacy, Safety, and Acceptability of Pharmacologic Treatments for Pediatric Migraine Prophylaxis: A Systematic Review and Network Meta-analysis. ( Barthel, J; Berde, CB; Gaab, J; Koechlin, H; Kossowsky, J; Lam, TL; Linde, K; Locher, C; Meissner, K; Schwarzer, G, 2020) |
| "At baseline, migraine patients had significantly higher VEP amplitudes and longer latencies than did a group of 87 healthy control subjects." | 2.66 | Central effects of drugs used in migraine prophylaxis evaluated by visual evoked potentials. ( Bille, A; Dichgans, J; Diener, HC; Gerber, WD; Jäck, A; Niederberger, U; Scholz, E, 1989) |
| "Nifedipine was effective in only 30% of patients (6/20)." | 2.66 | Nifedipine versus propranolol for the initial prophylaxis of migraine. ( Albers, GW; Hamik, A; Peroutka, SJ; Simon, LT, 1989) |
| "Twelve patients with classical migraine were included." | 2.66 | The difference between non-selective and beta 1-selective beta-blockers in their effect on platelet function in migraine patients. ( Hedman, C; Knudsen, JB; Winther, K, 1986) |
| "In 31 patients with at least 3 migraine attacks per month the prophylactic effect of tolfenamic acid 300 mg/day, propranolol 120 mg/day, and placebo was compared in a randomized double-blind cross-over study." | 2.66 | Prophylactic treatment of migraine with tolfenamic acid, propranolol and placebo. ( Christiansen, LV; Mikkelsen, B; Pedersen, KK, 1986) |
| "Among 1,036 patients treated for migraine headache between 1973 and 1980, 865 were given a daily maximum dose of 320 mg of propranolol, while 171 served as differently treated controls." | 2.65 | Observations on the efficacy of propranolol for the prophylaxis of migraine. ( Rosen, JA, 1983) |
| "Common migraine sufferers (25 males, 71 females) with a history of 2-6 attacks per month participated in a 4-centre trial comparing the prophylactic effect of timolol (10 mg b." | 2.65 | Timolol vs propranolol vs placebo in common migraine prophylaxis: a double-blind multicenter trial. ( Hakkarainen, H; Kangasneimi, P; Olesen, J; Standnes, B; Tfelt-Hansen, P, 1984) |
| "Metoprolol was used in a dosage of 50 mg b." | 2.65 | Metoprolol and propranolol in migraine prophylaxis: a double-blind multicentre study. ( Behring, HC; Forssman, B; Hedman, C; Hedman, G; Johansson, F; Kinnman, J; Olsson, JE; Pålhagen, SE; Samuelsson, M; Strandman, E, 1984) |
| "In a double-blind, cross-over study the effect and tolerance of the non-selective beta-blocker propranolol in a dosage of 80 mg twice daily was compared to that of the beta 1-selective beta-blocker metoprolol 200 mg once daily in Durules (a controlled-release formulation)." | 2.65 | Metoprolol and propranolol in the prophylactic treatment of classical and common migraine. A double-blind study. ( Hedman, C; Kangasniemi, P, 1984) |
| " The post-tyramine migraine index correlated directly with the amount of tyramine administered during the dose-response test (r = 0." | 2.65 | Mechanism of tyramine-induced migraine: similarity with dopamine and interactions with disulfiram and propranolol in migraine patients. ( Carroll, JD; Ghose, K, 1984) |
| " The daily dosage of propranolol and clonidine was 160 mg and 100 microgram, respectively." | 2.65 | Propranolol (Inderal) and clonidine (Catapressan) in the prophylactic treatment of migraine. A comparative trial. ( Kåss, B; Nestvold, K, 1980) |
| "and placebo were compared in 20 migraine patients." | 2.64 | Short-term clinical trial of phopranolol in racemic form (Inderal), D-propranolol and placebo in migraine. ( Sjaastad, O; Stensrud, P, 1976) |
| "As the pathogenesis of migraine is not completely understood, the mode of action of propranolol in preventing attacks cannot be fully explained." | 2.64 | Treatment of migraine with propranolol. ( Borgesen, SE, 1976) |
| "Propranolol seems to be an effective prophylactic for common and classic migraine but the antimigraine properties of the various beta-blocking agents probably differ." | 2.64 | Propranolol in the treatment of migraine. ( Vigander, T; Wideroe, TE, 1974) |
| "Propranolol was comparable to other medications known to be effective including flunarizine, topiramate and valproate." | 2.61 | Beta-blockers for the prevention of headache in adults, a systematic review and meta-analysis. ( Hayashino, Y; Jackson, JL; Jackson, W; Kuriyama, A; Kuwatsuka, Y; Nickoloff, S; Storch, D; Zhang, ZJ, 2019) |
| "The treatment of headache is usually successful and thus highly rewarding for physicians of all medical specialties." | 2.58 | Hints on Diagnosing and Treating Headache. ( May, A, 2018) |
| "We calculated MDs for Migraine Disability Assessment (MIDAS) scores." | 2.49 | Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults. ( Chronicle, EP; Linde, M; McCrory, DC; Mulleners, WM, 2013) |
| "Diagnosis of conversion disorder (hysteria) was grounded in the criteria set forth in the DSM-IV." | 2.48 | [Migraine associated with conversion symptoms (Babinski's migraine): evaluation of a series of 43 cases]. ( García-Albea, E, 2012) |
| "Migraine is usually managed by medication, but some patients do not tolerate migraine medication due to side effects or prefer to avoid medication for other reasons." | 2.47 | Manual therapies for migraine: a systematic review. ( Chaibi, A; Russell, MB; Tuchin, PJ, 2011) |
| "The improvement of migraine in the patients who recieved propranolol for angina pectoris revealed the effectiveness of propranolol in migraine prophylaxis." | 2.45 | [Beta blockers in migraine prophylaxis]. ( Shimizu, T, 2009) |
| "Children with abdominal migraine were identified from a group of children with NF1, all of whom had been followed up for a minimum of 3 years." | 2.41 | Abdominal migraine in children with neurofibromatosis type 1: a case series and review of gastrointestinal involvement in NF1. ( Bousvaros, A; Heuschkel, R; Kim, S; Korf, B; Schneider, G, 2001) |
| "Neurologists and PCPs chose migraine prophylaxis on the basis of scientific merit (r = 0." | 2.40 | Migraine prophylactic drugs: proof of efficacy, utilization and cost. ( Gilkey, SJ; Ramadan, NM; Schultz, LL, 1997) |
| "Propranolol was the most effective agent with reported benefit in four of six cases, other antimigraine agents were deemed effective in two of seven cases." | 2.39 | Prophylactic therapy in cyclic vomiting syndrome. ( Forbes, D; Withers, G, 1995) |
| "He discusses treatment of headache in relation to management of the acute attack, avoidance of trigger factors, and pharmacological and nonpharmacological prophylaxis." | 2.37 | An overview of the classification, causes, and treatment of headache. ( Ziegler, DK, 1984) |
| "Headache is a common chronic and recurrent symptom in children and adolescents." | 2.37 | Chronic and recurrent headaches in children and adolescents. ( Gascon, GG, 1984) |
| "Migraine is a hereditary disorder afflicting 5 per cent of school-age children." | 2.37 | Migraine in children. ( Fenichel, GM, 1985) |
| "Some patients with migraines do not benefit from the poor efficacy, side effects, or vasoconstrictive effects of triptan." | 1.91 | [Migraine Medication]. ( Kikui, S; Takeshima, T, 2023) |
| "Pretreatment with propranolol or nor-BNI prior to restraint stress prevented both transient cutaneous allodynia and priming, demonstrated by a lack of umbellulone-induced cutaneous allodynia." | 1.62 | A novel, injury-free rodent model of vulnerability for assessment of acute and preventive therapies reveals temporal contributions of CGRP-receptor activation in migraine-like pain. ( Chessell, IP; Dodick, DW; Kopruszinski, CM; Navratilova, E; Porreca, F; Swiokla, J, 2021) |
| "Vestibular migraine (VM) consists of recurrent episodes of vestibular symptoms that are accompanied by migraine in at least 50% of the episodes." | 1.56 | Analysis of the effectiveness of the prophylaxis of vestibular migraine depending on the diagnostic category and the prescribed drug. ( Álvarez-Morujo de Sande, MG; Bécares-Martínez, C; Domènech-Vadillo, E; Domínguez-Durán, E; González-Aguado, R; Guerra-Jiménez, G; Montilla-Ibáñez, MA, 2020) |
| "The mean pre-treatment Dizziness Handicap Inventory score was 57." | 1.56 | Pharmacotherapy failure and progression to botulinum toxin injection in vestibular migraine. ( Donaldson, L; Dornhoffer, JR; Liu, YF; Macias, D; Rizk, HG, 2020) |
| "For mild migraine, symptomatic treatment with high dose simple analgesics is suggested, while for moderate to severe migraines triptans or non-steroidal anti-inflammatory drugs, or both, should be administered following an individually tailored therapeutic strategy." | 1.51 | Consensus of the Hellenic Headache Society on the diagnosis and treatment of migraine. ( Arvaniti, C; Constantinidis, TS; Fakas, N; Giannouli, E; Kalamatas, T; Kararizou, E; Kouremenos, E; Mitsikostas, DD; Naoumis, D, 2019) |
| "Background Migraine is a highly prevalent and disabling disorder of the brain with limited therapeutic options, particularly for preventive treatment." | 1.48 | Comparative effects of traditional Chinese and Western migraine medicines in an animal model of nociceptive trigeminovascular activation. ( Akerman, S; Goadsby, PJ; Martins-Oliveira, M; Zhao, Y, 2018) |
| "Background The development of novel migraine therapies has been slow, in part because of the small number of clinically relevant animal models." | 1.43 | The effects of acute and preventive migraine therapies in a mouse model of chronic migraine. ( Charles, A; McGuire, B; Pradhan, AA; Tarash, I; Tipton, AF, 2016) |
| "Prophylactic therapy response varies in migraine patients." | 1.43 | Association of MDR1, CYP2D6, and CYP2C19 gene polymorphisms with prophylactic migraine treatment response. ( Ak, S; Atasayar, G; Can, FE; Cecener, G; Egeli, U; Eryilmaz, IE; Karli, N; Taskapilioglu, O; Tezcan, G; Tunca, B; Yildirim, O; Zarifoglu, M, 2016) |
| "The medical files of patients with migraine attending the headache clinic of a tertiary pediatric medical center in 2010-2015 were reviewed." | 1.43 | Factors Influencing Response to Pharmacologic Treatment of Migraine in a Pediatric Headache Clinic. ( Haimi-Cohen, Y; Markus, TE; Moad, B; Zeharia, A, 2016) |
| "Many migraine sufferers use daily prophylactic therapy to reduce the frequency of their headache attacks." | 1.43 | Using a graphical risk tool to examine willingness to take migraine prophylactic medications. ( Golding, AN; Houle, TT; Turner, DP, 2016) |
| "For propranolol, 31 patients were treated and there was an improvement of symptoms in 73% (p < 0." | 1.42 | Vestibular migraine in an otolaryngology clinic: prevalence, associated symptoms, and prophylactic medication effectiveness. ( Van de Heyning, P; Van Ombergen, A; Van Rompaey, V; Wuyts, F, 2015) |
| "Evidence-based interventions for migraine should have as much a claim on scarce health resources as those for other chronic, non-communicable conditions that impose a significant burden on societies." | 1.42 | Cost-effectiveness analysis of interventions for migraine in four low- and middle-income countries. ( Chisholm, D; Linde, M; Steiner, TJ, 2015) |
| "A few of these may suffer from abdominal migraine and can be treated well with antimigraine medication." | 1.40 | [Attacks of abdominal pain can be abdominal migraine]. ( Nøjgaard, C; Rasmussen, E, 2014) |
| "Propranolol is a non-selective beta-adrenergic receptor blocker used in the treatment of cardiovascular diseases and migraine prophylaxis." | 1.39 | Propranolol-induced relaxation in the rat basilar artery. ( Babaoglu, MO; Cekic, EG; Guler, S; Soydan, G; Tuncer, M, 2013) |
| "These findings indicate that: (a) migraine is the most frequent cause of headache in pediatric patients, (b) it has negative effects on school performance and daily activities, (c) the family history is important for making the diagnosis and (d) prophylaxis is significantly effective." | 1.36 | Profile of children with migraine. ( Aydin, M; Bozdag, S; Ertugrul, S; Kabakus, N, 2010) |
| "Thalamic involvement in migraine is attractive given the complex and widespread nature of the sensory disturbance." | 1.33 | Propranolol modulates trigeminovascular responses in thalamic ventroposteromedial nucleus: a role in migraine? ( Goadsby, PJ; Shields, KG, 2005) |
| "(6) Flunarizine also has documented efficacy, but this "hidden neuroleptic" can cause extrapyramidal disorders and weight gain." | 1.33 | Pharmacological prevention of migraine: to be considered case by case. ( , 2006) |
| "In Study 1, 12 migraine with aura patients (MA), 12 age-matched migraine without aura patients (MO) and 12 age- and sex-matched headache-free control subjects (C) were compared using the metacontrast test." | 1.31 | Cortical hyperexcitability is cortical under-inhibition: evidence from a novel functional test of migraine patients. ( Chronicle, EP; Mulleners, WM; Palmer, JE; Rolan, P, 2000) |
| " Therefore, it is quite possible that both drugs produce adverse immunological effects in vivo in cases of high dosage or obstruction of elimination." | 1.31 | [Effect of migraine medications on monocyte chemotaxis] . ( Krumholz, W; Menges, T; Ogal, H; Szalay, G, 2000) |
| "Successful migraine relief was achieved with a combination of propranolol and naproxen, administered before and after ECT." | 1.31 | Successful use of propranolol in migraine associated with electroconvulsive therapy. ( Delva, NJ; Hawken, ER; Lawson, JS, 2001) |
| "Of the prophylactic antimigraine drugs tested, methysergide and lisuride behaved as efficacious agonists (Emax > or = 90% relative to 5-HT) whereas pitozifen and (-)propranolol acted as a partial agonist (60%) and an antagonist, respectively." | 1.30 | Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy. ( Audinot-Bouchez, V; Chaput, C; Conte, C; Lavielle, G; Lochon, S; Millan, MJ; Newman-Tancredi, A; Verrièle, L, 1997) |
| " Measures of dosing interval--used-on-schedule rate and therapeutic coverage--averaged between 44% and 71%." | 1.30 | Noncompliance may render migraine prophylaxis useless, but once-daily regimens are better. ( Mulleners, WM; Steiner, TJ; Whitmarsh, TE, 1998) |
| "The patients with common migraine responded to beta blocker therapy." | 1.30 | Contingent negative variation in migraine: effect of beta blocker therapy. ( Ahmed, I, 1999) |
| "Although the cause of migraine remains poorly understood, there is considerable evidence to support a role of the neurotransmitter serotonin in the pathophysiology of migraine." | 1.30 | Increased brain serotonin synthesis in migraine. ( Chaturvedi, S; Chugani, DC; Chugani, HT; Fakhouri, M; Lee, ML; Muzik, O; Niimura, K, 1999) |
| "The response to prophylactic anti-migraine medication (propranolol or amitriptyline used alone or in combination) was gratifying, with 21 of 30 adequately treated patients (70%) reporting dramatic reduction in the frequency and severity of their headaches." | 1.28 | Post-traumatic migraine: chronic migraine precipitated by minor head or neck trauma. ( Goldberg, J; Stern, BJ; Weiss, HD, 1991) |
| "We followed-up 64 migraine patients after discontinuation of successful interval prophylaxis with flunarizine, propranolol or metoprolol, to investigate how long the therapeutic success would last, if further prophylaxis would be successful again, and what factors would influence the prognosis." | 1.28 | Long-term results of migraine prophylaxis with flunarizine and beta-blockers. ( Koch, G; Wessely, P; Wöber, C; Wöber-Bingöl, C, 1991) |
| "Propranolol-HCl has proven to be an effective treatment." | 1.28 | Hearing fluctuation during migraine attacks. Activity of propranolol-HCl in rats. ( Bernard, PA; Bourret, CS; Stenstrom, R, 1991) |
| "Slit ventricle syndrome is characterized by chronic or recurring headaches associated with subnormal ventricular volume in patients who have undergone shunt treatment for hydrocephalus." | 1.28 | Antimigraine treatment for slit ventricle syndrome. ( Cogen, PH; Edwards, MS; Obana, WG; Raskin, NH; Szymanski, JA, 1990) |
| "We conclude that in patients with hydrocephalus and repeated bouts of symptoms such as headaches, vomiting, and impairment of consciousness and in the case of documented, adequate shunt function, the diagnosis of migraine be entertained before further operative intervention is undertaken." | 1.28 | Migraine headaches in hydrocephalic children: a diagnostic dilemma. ( James, HE; Nowak, TP, 1989) |
| "Improvement of migraine index was not related to different plasma levels of the two drugs." | 1.27 | Propranolol and acetylsalicylic acid in migraine prophylaxis. Double-blind crossover study. ( Baldrati, A; Baruzzi, A; Cortelli, P; D'Alessandro, R; Gamberini, G; Procaccianti, G; Sacquegna, T, 1983) |
| "The treatment of migraine includes the avoidance of precipitating factors when possible, psychological counselling and relaxation training." | 1.27 | The pharmacotherapy of migraine. ( Lance, JW, 1986) |
| "Thirty-three patients with common migraine underwent contingent negative variation (CNV) recordings before receiving prophylactic beta-blocker treatment with either metoprolol (27 patients) or propranolol (6 patients) at mean daily dosages of 110 mg and 122 mg, respectively." | 1.27 | Contingent negative variation and efficacy of beta-blocking agents in migraine. ( Maertens de Noordhout, A; Schoenen, J; Timsit, M; Timsit-Berthier, M, 1986) |
| "The prophylactic treatment of migraine with beta blockers is at present well established, and non-selective as well as beta 1-selective beta blockers exert an effect." | 1.27 | Beta-adrenoceptor blockade, platelets, and rheologic factors. ( Hedman, C; Winther, K, 1986) |
| "beta-Adrenoceptor blockers effective in migraine prophylaxis include propranolol (nonselective) and metoprolol (beta 1-selective), but it is uncertain how beta-receptor subtype selectivity might influence platelet behavior in migraine." | 1.27 | Platelet activity and selective beta-blockade in migraine prophylaxis. ( Clifford Rose, F; Joseph, R; Schultz, LU; Steiner, TJ, 1988) |
| "Vestibular symptoms commonly occur in migraine, and episodic vertigo is most frequently seen." | 1.27 | Episodic vertigo in basilar artery migraine. ( Harker, LA; Rassekh, CH, 1987) |
| "It is concluded that migraine responds to flunarizine and to other commonly used prophylactics in a similar way and with similar kinetics." | 1.27 | Onset of action of various migraine prophylactics. ( Amery, WK, 1988) |
| "Treatment with propranolol hydrochloride (HCl), a potent beta-blocker, resulted in cessation of hearing fluctuations in all patients and in an improvement of thresholds in two of them." | 1.27 | Fluctuating hearing losses in children can be migraine equivalents. ( Bernard, PA; Stenstrom, RJ, 1988) |
| "Seventy seven cases of migraine in children were studied." | 1.27 | [Headache in childhood: diagnosis and therapy. A prospective study of 77 cases]. ( Muszkat, M; Torres, DM; Vergani, MI, 1988) |
| "For one, migraines are often accompanied by other symptoms, such as nausea and vomiting." | 1.27 | Childhood migraine. Differential diagnosis and treatment. ( MacDonald, JT, 1986) |
| "In the prophylaxis of migraine beta-blockers are commonly used." | 1.27 | Combination headache: practical experience with a combination of a beta-blocker and an antidepressive. ( Kellhammer, U; Pfaffenrath, V; Pöllmann, W, 1986) |
| "Benefits of migraine therapy include improvements in the patient's overall health and sense of well-being." | 1.27 | Management of the migraine patient. ( Gunderson, CH, 1986) |
| " Propranolol decreased the migraine index more than 70% in 13 patients: five patients at a dosage of 40 mg/day, five patients at a dosage of 120 mg/day, and three patients at a dosage of 240 mg/day." | 1.27 | Propranolol plasma levels and relief of migraine. Relationship between plasma propranolol and 4-hydroxypropranolol concentrations and clinical effects. ( Albani, F; Baldrati, A; Baruzzi, A; Cortelli, P; D'Alessandro, R; Lugaresi, E; Sacquegna, T, 1985) |
| "Three days after initiation of migraine headache therapy with ergotamine tartrate and propranolol, severe acute arterial insufficiency of the lower extremities developed in a 48-year-old woman who had been in general good health." | 1.26 | Lower extremity ischemia due to combined drug therapy for migraine. ( Greenberg, DJ; Hallett, JW, 1982) |
| "Two patients with histories of migraine had ischemic optic neuropathy develop during an episode of migraine." | 1.26 | Ischemic optic neuropathy in migraine. ( Feman, SS; Weinstein, JM, 1982) |
| " Preliminary results of prophylactic treatment with propranolol are encouraging; smaller dosage than those previously recommended sometimes can be effective." | 1.26 | Hemiplegic migraine in childhood: diagnostic and therapeutic aspects. ( Lai, CW; Lansky, LL; Torres, F; Ziegler, DK, 1982) |
| "They are effective in any fast arrhythmia." | 1.26 | Present state of alpha and beta adrenergic drugs III. Beta blocking agents. ( Ahlquist, RP, 1977) |
| "The responsiveness of both migraine headaches and carotidynia to similar drugs suggests a common pathophysiologic mechanism." | 1.26 | Carotidynia. ( Prusiner, S; Raskin, NH, 1977) |
| "Three of the 10 members had hemiplegic migraine attacks associated with minor head trauma." | 1.25 | Familial hemiplegic migraine. ( Glista, GG; Mellinger, JF; Rooke, ED, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 187 (52.82) | 18.7374 |
| 1990's | 56 (15.82) | 18.2507 |
| 2000's | 43 (12.15) | 29.6817 |
| 2010's | 49 (13.84) | 24.3611 |
| 2020's | 19 (5.37) | 2.80 |
| Authors | Studies |
|---|---|
| Chowdhury, D | 1 |
| Bansal, L | 1 |
| Duggal, A | 1 |
| Datta, D | 1 |
| Mundra, A | 1 |
| Krishnan, A | 1 |
| Koul, A | 1 |
| Gupta, A | 1 |
| Shafie'ei, M | 1 |
| Kouhanjani, MF | 1 |
| Akbari, Z | 1 |
| Sarvipour, N | 1 |
| Shekouh, D | 1 |
| Gholampour, M | 1 |
| Ardestani, PM | 1 |
| Nemati, H | 1 |
| Yiannakis, C | 1 |
| Hamilton, L | 1 |
| Slim, M | 1 |
| Kontorinis, G | 1 |
| Adeeb Sheet, D | 1 |
| Bibani, RH | 1 |
| Kheder, AH | 1 |
| Kikui, S | 1 |
| Takeshima, T | 1 |
| Carcel, C | 1 |
| Haghdoost, F | 1 |
| Shen, J | 1 |
| Nanda, P | 1 |
| Bai, Y | 1 |
| Atkins, E | 1 |
| Torii-Yoshimura, T | 1 |
| Clough, AJ | 1 |
| Davies, L | 1 |
| Cordato, D | 1 |
| Griffiths, LR | 1 |
| Balicki, G | 1 |
| Wang, X | 1 |
| Vidyasagar, K | 1 |
| Malavera, A | 1 |
| Anderson, CS | 1 |
| Zagami, AS | 1 |
| Delcourt, C | 1 |
| Rodgers, A | 1 |
| Ingram, EE | 1 |
| Bocklud, BE | 1 |
| Corley, SC | 1 |
| Granier, MA | 1 |
| Neuchat, EE | 1 |
| Ahmadzadeh, S | 1 |
| Shekoohi, S | 1 |
| Kaye, AD | 1 |
| Chen, JJ | 1 |
| Zeng, BS | 1 |
| Su, KP | 1 |
| Wu, YC | 1 |
| Tu, YK | 1 |
| Stubbs, B | 1 |
| Chen, TY | 1 |
| Zeng, BY | 1 |
| Chen, YW | 1 |
| Hsu, CW | 1 |
| Tseng, PT | 1 |
| Chen, YY | 1 |
| Li, J | 1 |
| Chen, M | 1 |
| Yue, L | 1 |
| She, TW | 1 |
| Zheng, H | 1 |
| Kouremenos, E | 1 |
| Arvaniti, C | 1 |
| Constantinidis, TS | 1 |
| Giannouli, E | 1 |
| Fakas, N | 1 |
| Kalamatas, T | 1 |
| Kararizou, E | 1 |
| Naoumis, D | 1 |
| Mitsikostas, DD | 2 |
| Tsai, M | 1 |
| Case, M | 1 |
| Ardayfio, P | 1 |
| Hochstetler, H | 1 |
| Wilbraham, D | 1 |
| Domínguez-Durán, E | 1 |
| Montilla-Ibáñez, MA | 1 |
| Álvarez-Morujo de Sande, MG | 1 |
| Domènech-Vadillo, E | 1 |
| Bécares-Martínez, C | 1 |
| González-Aguado, R | 1 |
| Guerra-Jiménez, G | 1 |
| Locher, C | 1 |
| Kossowsky, J | 1 |
| Koechlin, H | 1 |
| Lam, TL | 1 |
| Barthel, J | 1 |
| Berde, CB | 1 |
| Gaab, J | 1 |
| Schwarzer, G | 1 |
| Linde, K | 3 |
| Meissner, K | 1 |
| Gaki, E | 1 |
| Siapkara, A | 1 |
| Morgan, S | 1 |
| Branch, S | 1 |
| Liu, YF | 1 |
| Macias, D | 1 |
| Donaldson, L | 1 |
| Dornhoffer, JR | 1 |
| Rizk, HG | 1 |
| Kopruszinski, CM | 1 |
| Navratilova, E | 1 |
| Swiokla, J | 1 |
| Dodick, DW | 2 |
| Chessell, IP | 1 |
| Porreca, F | 1 |
| Tchivileva, IE | 1 |
| Ohrbach, R | 1 |
| Fillingim, RB | 1 |
| Lim, PF | 1 |
| Giosia, MD | 1 |
| Ribeiro-Dasilva, M | 1 |
| Campbell, JH | 1 |
| Hadgraft, H | 1 |
| Willis, J | 1 |
| Arbes, SJ | 1 |
| Slade, GD | 1 |
| Drellia, K | 1 |
| Kokoti, L | 1 |
| Deligianni, CI | 1 |
| Papadopoulos, D | 1 |
| Nakamura, M | 1 |
| Jang, IS | 1 |
| Zhao, Y | 1 |
| Martins-Oliveira, M | 1 |
| Akerman, S | 1 |
| Goadsby, PJ | 2 |
| Ben Aissa, M | 1 |
| Tipton, AF | 2 |
| Bertels, Z | 1 |
| Gandhi, R | 1 |
| Moye, LS | 1 |
| Novack, M | 1 |
| Bennett, BM | 1 |
| Wang, Y | 1 |
| Litosh, V | 1 |
| Lee, SH | 1 |
| Gaisina, IN | 1 |
| Thatcher, GR | 1 |
| Pradhan, AA | 2 |
| Bulboacă, AE | 1 |
| Bolboacă, SD | 1 |
| Stănescu, IC | 1 |
| Sfrângeu, CA | 1 |
| Bulboacă, AC | 1 |
| May, A | 1 |
| Kurauchi, Y | 1 |
| Haruta, M | 1 |
| Tanaka, R | 1 |
| Sasagawa, K | 1 |
| Ohta, J | 1 |
| Hisatsune, A | 1 |
| Seki, T | 1 |
| Katsuki, H | 1 |
| Jackson, JL | 1 |
| Kuriyama, A | 1 |
| Kuwatsuka, Y | 1 |
| Nickoloff, S | 1 |
| Storch, D | 1 |
| Jackson, W | 1 |
| Zhang, ZJ | 1 |
| Hayashino, Y | 1 |
| Çelik, O | 1 |
| Tanyeri Toker, G | 1 |
| Eskiizmir, G | 1 |
| İncesulu, A | 1 |
| Şahin Süyür, N | 1 |
| Fallah, R | 1 |
| Divanizadeh, MS | 1 |
| Karimi, M | 1 |
| Mirouliaei, M | 1 |
| Shamszadeh, A | 1 |
| Israil, A | 1 |
| Ahmed, S | 1 |
| Rahman, KM | 1 |
| Uddin, MJ | 1 |
| Dey, SK | 1 |
| Battacharjee, M | 1 |
| Mondal, G | 1 |
| Ali, MA | 1 |
| Alam, MN | 1 |
| Miah, AH | 1 |
| Uddin, MS | 1 |
| Linde, M | 3 |
| Mulleners, WM | 3 |
| Chronicle, EP | 2 |
| McCrory, DC | 1 |
| Goncalves, DA | 1 |
| Camparis, CM | 1 |
| Speciali, JG | 1 |
| Castanharo, SM | 1 |
| Ujikawa, LT | 1 |
| Lipton, RB | 1 |
| Bigal, ME | 1 |
| Stovner, LJ | 1 |
| Gravdahl, GB | 1 |
| Tronvik, E | 1 |
| Aamodt, AH | 1 |
| Sand, T | 1 |
| Hagen, K | 1 |
| Smelt, AF | 1 |
| Assendelft, WJ | 1 |
| van Dijk, CE | 1 |
| Blom, JW | 1 |
| Millán-Guerrero, RO | 1 |
| Isais-Millán, R | 1 |
| Guzmán-Chávez, B | 1 |
| Castillo-Varela, G | 1 |
| Cady, RK | 1 |
| Topcu, Y | 1 |
| Hiz Kurul, S | 1 |
| Bayram, E | 1 |
| Sozmen, K | 1 |
| Yis, U | 1 |
| Van Ombergen, A | 1 |
| Van Rompaey, V | 1 |
| Van de Heyning, P | 1 |
| Wuyts, F | 1 |
| Rasmussen, E | 1 |
| Nøjgaard, C | 1 |
| Steiner, TJ | 4 |
| Chisholm, D | 1 |
| Bakhshandeh Bali, M | 1 |
| Rahbarimanesh, AA | 1 |
| Sadeghi, M | 1 |
| Sedighi, M | 1 |
| Karimzadeh, P | 1 |
| Ghofrani, M | 1 |
| Salviz, M | 1 |
| Yuce, T | 1 |
| Acar, H | 1 |
| Karatas, A | 1 |
| Acikalin, RM | 1 |
| Farkas, B | 1 |
| Kardos, P | 1 |
| Orosz, S | 1 |
| Tarnawa, I | 1 |
| Csekő, C | 1 |
| Lévay, G | 1 |
| Farkas, S | 1 |
| Lendvai, B | 1 |
| Kovács, P | 1 |
| Tarash, I | 1 |
| McGuire, B | 1 |
| Charles, A | 1 |
| Jafarpour, M | 1 |
| Yousefi, G | 1 |
| Hamedi, A | 1 |
| Shariat, A | 1 |
| Salehi, A | 1 |
| Heydari, M | 1 |
| Tajadini, H | 1 |
| Zangiabadi, N | 1 |
| Divsalar, K | 1 |
| Safizadeh, H | 1 |
| Esmaili, Z | 1 |
| Rafiei, H | 1 |
| Atasayar, G | 1 |
| Eryilmaz, IE | 1 |
| Karli, N | 1 |
| Egeli, U | 1 |
| Zarifoglu, M | 1 |
| Cecener, G | 1 |
| Taskapilioglu, O | 1 |
| Tunca, B | 1 |
| Yildirim, O | 1 |
| Ak, S | 1 |
| Tezcan, G | 1 |
| Can, FE | 1 |
| Markus, TE | 1 |
| Moad, B | 1 |
| Haimi-Cohen, Y | 2 |
| Zeharia, A | 2 |
| Lamb, L | 1 |
| Lowe, D | 1 |
| Turner, DP | 1 |
| Golding, AN | 1 |
| Houle, TT | 1 |
| Rossnagel, K | 2 |
| He, A | 1 |
| Song, D | 1 |
| Zhang, L | 1 |
| Li, C | 1 |
| Ashtari, F | 1 |
| Shaygannejad, V | 1 |
| Akbari, M | 1 |
| Yaldo, AZ | 1 |
| Wertz, DA | 1 |
| Rupnow, MF | 1 |
| Quimbo, RM | 1 |
| Sri-udomkajorn, S | 1 |
| Ruangsuwan, S | 1 |
| Diener, HC | 8 |
| Danesch, U | 1 |
| Hirfanoglu, T | 1 |
| Serdaroglu, A | 1 |
| Gulbahar, O | 1 |
| Cansu, A | 1 |
| Bermejo, PE | 1 |
| Dorado, R | 1 |
| Gomez-Arguelles, JM | 1 |
| Shimizu, T | 1 |
| Firnhaber, JM | 1 |
| Rickett, K | 1 |
| Keyvan, G | 1 |
| Abolfazl, MB | 1 |
| Domingues, RB | 1 |
| Silva, AL | 1 |
| Domingues, SA | 1 |
| Aquino, CC | 1 |
| Kuster, GW | 1 |
| Silcocks, P | 1 |
| Whitham, D | 1 |
| Whitehouse, WP | 1 |
| Bidabadi, E | 1 |
| Mashouf, M | 1 |
| Seng, EK | 1 |
| Holroyd, KA | 4 |
| Aydin, M | 1 |
| Kabakus, N | 1 |
| Bozdag, S | 1 |
| Ertugrul, S | 1 |
| Chaibi, A | 1 |
| Tuchin, PJ | 1 |
| Russell, MB | 1 |
| Liao, KY | 1 |
| Chang, FY | 1 |
| Wu, LT | 1 |
| Wu, TC | 1 |
| Bülow-Olsen, A | 1 |
| Min, JH | 1 |
| Kwon, HM | 1 |
| Nam, H | 1 |
| Bendtsen, L | 1 |
| García-Albea, E | 1 |
| Pascual, J | 4 |
| Silberstein, SD | 2 |
| Lindblad, AS | 1 |
| Holroyd, K | 1 |
| Harrington, M | 1 |
| Mathew, NT | 2 |
| Hirtz, D | 1 |
| Togha, M | 1 |
| Malamiri, RA | 1 |
| Rashidi-Ranjbar, N | 1 |
| Asa, S | 1 |
| Mahvelati, F | 1 |
| Ashrafi, MR | 2 |
| Eidlitz-Markus, T | 1 |
| Dlugatch, Y | 1 |
| Goldberg-Stern, H | 1 |
| Cekic, EG | 1 |
| Soydan, G | 1 |
| Guler, S | 1 |
| Babaoglu, MO | 1 |
| Tuncer, M | 1 |
| Spry, H | 1 |
| McDiarmid, T | 1 |
| Mayer, J | 1 |
| Stanton, RN | 1 |
| Ignatov, IuD | 1 |
| Skoromets, AA | 1 |
| Amelin, AV | 1 |
| Barnes, N | 2 |
| Millman, G | 2 |
| Tfelt-Hansen, P | 4 |
| Dahlöf, C | 2 |
| Láinez, MJ | 2 |
| Sandrini, G | 1 |
| Wang, SJ | 1 |
| Neto, W | 1 |
| Vijapurkar, U | 1 |
| Doyle, A | 1 |
| Jacobs, D | 1 |
| Shields, KG | 1 |
| Mannix, LK | 1 |
| Wammes-van der Heijden, EA | 1 |
| Smidt, MH | 1 |
| Tijssen, CC | 1 |
| van't Hoff, AR | 1 |
| Lenderink, AW | 1 |
| Egberts, AC | 1 |
| Richter, F | 1 |
| Mikulik, O | 1 |
| Ebersberger, A | 1 |
| Schaible, HG | 1 |
| Evans, RW | 1 |
| Leira, R | 2 |
| Shabanian, R | 1 |
| Zamani, GR | 1 |
| Mahfelati, F | 1 |
| Kaushik, R | 1 |
| Kaushik, RM | 1 |
| Mahajan, SK | 1 |
| Rajesh, V | 1 |
| James, E | 1 |
| Rivas, MT | 1 |
| Ridley-Smith, RM | 1 |
| Medeiros, FL | 1 |
| Medeiros, PL | 1 |
| Valença, MM | 1 |
| Dodick, D | 1 |
| Gupta, VK | 1 |
| Anthony, M | 2 |
| Koch-Weser, J | 1 |
| Frishman, WH | 1 |
| Obukhov, GA | 1 |
| Patel, L | 2 |
| Turner, P | 3 |
| Weerasuriya, K | 1 |
| Parentela, A | 1 |
| Montorsi, P | 1 |
| Doogan, DP | 1 |
| Johnson, JM | 1 |
| Zahavi, I | 2 |
| Chagnac, A | 1 |
| Hering, R | 2 |
| Davidovich, S | 1 |
| Kuritzky, A | 2 |
| Jackson, EA | 1 |
| Sullman, SA | 1 |
| Joseph, R | 2 |
| Ryan, RE | 2 |
| Maxwell, RE | 1 |
| Rosen, JA | 1 |
| Palferman, TG | 1 |
| Gibberd, FB | 1 |
| Simmonds, JP | 1 |
| Sicuteri, F | 2 |
| Barabas, G | 1 |
| Standnes, B | 2 |
| Kangasneimi, P | 1 |
| Hakkarainen, H | 1 |
| Olesen, J | 2 |
| Ziegler, DK | 5 |
| Gascon, GG | 1 |
| Olsson, JE | 1 |
| Behring, HC | 1 |
| Forssman, B | 2 |
| Hedman, C | 5 |
| Hedman, G | 1 |
| Johansson, F | 1 |
| Kinnman, J | 1 |
| Pålhagen, SE | 1 |
| Samuelsson, M | 1 |
| Strandman, E | 1 |
| Peatfield, R | 2 |
| Kangasniemi, P | 2 |
| Venter, CP | 1 |
| Joubert, PH | 1 |
| Buys, AC | 1 |
| Damasio, H | 2 |
| Albani, F | 4 |
| Riva, R | 2 |
| Baldrati, A | 4 |
| Cortelli, P | 7 |
| Perucca, E | 1 |
| Procaccianti, G | 2 |
| Baruzzi, A | 4 |
| Gengo, FM | 1 |
| Fagan, SC | 1 |
| Kinkel, WR | 1 |
| McHugh, WB | 1 |
| Eggers, C | 1 |
| Forsythe, WI | 2 |
| Gillies, D | 1 |
| Sills, MA | 1 |
| Ghose, K | 1 |
| Carroll, JD | 2 |
| Kangasniemi, PJ | 1 |
| Nyrke, T | 2 |
| Lang, AH | 2 |
| Petersen, E | 2 |
| Turkewitz, LJ | 1 |
| Sahgal, V | 1 |
| Spiro, A | 1 |
| Baker, CC | 1 |
| Featherstone, HJ | 2 |
| Greenberg, DJ | 1 |
| Hallett, JW | 1 |
| Sacquegna, T | 3 |
| D'Alessandro, R | 3 |
| De Carolis, P | 1 |
| Santucci, M | 1 |
| Lugaresi, E | 2 |
| Gamberini, G | 1 |
| Lund, M | 1 |
| Gever, LN | 1 |
| Ambielli, M | 1 |
| Behan, PO | 1 |
| Reid, M | 1 |
| Stensrud, P | 3 |
| Sjaastad, O | 3 |
| Kåss, B | 1 |
| Nestvold, K | 1 |
| Andersson, PG | 1 |
| Petersen, EN | 1 |
| Friedman, AP | 3 |
| Fozard, JR | 1 |
| McCann, J | 1 |
| Klimek, A | 4 |
| Nevodnichiĭ, A | 1 |
| Weitz, R | 1 |
| Gilbert, GJ | 1 |
| Weinstein, JM | 1 |
| Feman, SS | 1 |
| Harbaugh, RE | 1 |
| Saunders, RL | 1 |
| Reeves, AG | 1 |
| Lai, CW | 1 |
| Lansky, LL | 1 |
| Torres, F | 1 |
| Steardo, L | 1 |
| Bonuso, S | 2 |
| Di Stasio, E | 2 |
| Marano, E | 2 |
| Clark, BG | 1 |
| Araki, M | 1 |
| Rawlings, JL | 1 |
| Diamond, S | 5 |
| Kudrow, L | 2 |
| Stevens, J | 2 |
| Shapiro, DB | 1 |
| Prendes, JL | 2 |
| Bahemuka, M | 1 |
| Yamamoto, M | 1 |
| Meyer, JS | 1 |
| Raskin, NH | 3 |
| Schwartz, RK | 1 |
| O'Hare, JA | 1 |
| Feely, MJ | 1 |
| Callaghan, N | 2 |
| Peatfield, RC | 1 |
| Rose, FC | 2 |
| Schoenen, J | 3 |
| Parrish, DO | 1 |
| Todorov, AB | 1 |
| Drummond, PD | 1 |
| Lance, JW | 2 |
| Medina, JL | 3 |
| Kline, LB | 1 |
| Kelly, CL | 1 |
| Coffman, JD | 1 |
| Cohen, RA | 1 |
| France, JL | 1 |
| Cordingley, GE | 2 |
| Rokicki, LA | 1 |
| Kvaal, SA | 1 |
| Lipchik, GL | 1 |
| McCool, HR | 1 |
| Caballero, F | 1 |
| Sanz, C | 1 |
| Gil, E | 1 |
| Kjaersgård Rasmussen, MJ | 1 |
| Holt Larsen, B | 1 |
| Borg, L | 1 |
| Soelberg Sørensen, P | 1 |
| Hansen, PE | 1 |
| Constantinescu, CS | 1 |
| Chang, AP | 1 |
| McCluskey, LF | 1 |
| Hurwitz, A | 2 |
| Preskorn, S | 1 |
| Hassanein, R | 1 |
| Seim, J | 1 |
| Martínez-Mir, I | 1 |
| Navarro-Badenes, J | 1 |
| Palop, V | 1 |
| Morales-Olivas, FJ | 1 |
| Rubio, E | 1 |
| al-Qassab, HK | 1 |
| Findley, LJ | 1 |
| Dahlöf, CG | 1 |
| Forbes, D | 1 |
| Withers, G | 1 |
| Wiedemann, M | 1 |
| de Lima, VM | 1 |
| Hanke, W | 1 |
| Verspeelt, J | 2 |
| De Locht, P | 2 |
| Amery, WK | 3 |
| Föh, M | 1 |
| Iaccarino, C | 1 |
| Wessely, P | 2 |
| Isler, H | 2 |
| Strenge, H | 1 |
| Fischer, M | 1 |
| Wedekind, W | 1 |
| Taneri, Z | 1 |
| Ramadan, NM | 1 |
| Schultz, LL | 1 |
| Gilkey, SJ | 1 |
| Newman-Tancredi, A | 1 |
| Conte, C | 1 |
| Chaput, C | 1 |
| Verrièle, L | 1 |
| Audinot-Bouchez, V | 1 |
| Lochon, S | 1 |
| Lavielle, G | 1 |
| Millan, MJ | 1 |
| Kaniecki, RG | 1 |
| Mendizabal, JE | 1 |
| Greiner, F | 1 |
| Hamilton, WJ | 1 |
| Rothrock, JF | 1 |
| Nicolodi, M | 1 |
| Del Bianco, PL | 1 |
| Brune, K | 1 |
| Gerber, WD | 4 |
| Göbel, H | 1 |
| Pfaffenrath, V | 3 |
| Whitmarsh, TE | 1 |
| Baxt, WG | 1 |
| Waeckerle, JF | 1 |
| Berlin, JA | 1 |
| Callaham, ML | 1 |
| de Angelis, S | 1 |
| Amato, D | 1 |
| Scellini, T | 1 |
| Caruso, G | 1 |
| Worawattanakul, M | 1 |
| Rhoads, JM | 1 |
| Lichtman, SN | 1 |
| Ulshen, MH | 1 |
| Ahmed, I | 1 |
| Deleu, D | 1 |
| Hanssens, Y | 1 |
| Chugani, DC | 1 |
| Niimura, K | 1 |
| Chaturvedi, S | 1 |
| Muzik, O | 1 |
| Fakhouri, M | 1 |
| Lee, ML | 1 |
| Chugani, HT | 1 |
| Duckmanton, L | 1 |
| Rao, BS | 1 |
| Das, DG | 1 |
| Taraknath, VR | 1 |
| Sarma, Y | 1 |
| Palmer, JE | 1 |
| Rolan, P | 1 |
| Krumholz, W | 1 |
| Szalay, G | 1 |
| Ogal, H | 1 |
| Menges, T | 1 |
| Hawken, ER | 1 |
| Delva, NJ | 1 |
| Lawson, JS | 1 |
| Fleishaker, JC | 1 |
| Sisson, TA | 1 |
| Carel, BJ | 1 |
| Azie, NE | 1 |
| Krupp, P | 1 |
| Schmitt, T | 1 |
| Steitz, G | 1 |
| Milde, K | 1 |
| Freytag, S | 1 |
| Micieli, G | 1 |
| Cavallini, A | 1 |
| Marcheselli, S | 1 |
| Mailland, F | 1 |
| Ambrosoli, L | 1 |
| Nappi, G | 2 |
| Heuschkel, R | 1 |
| Kim, S | 1 |
| Korf, B | 1 |
| Schneider, G | 1 |
| Bousvaros, A | 1 |
| Russell, G | 1 |
| Abu-Arafeh, I | 1 |
| Symon, DN | 1 |
| Evers, S | 1 |
| Pothmann, R | 1 |
| Uberall, M | 1 |
| Naumann, E | 1 |
| Matias-Guiu, J | 1 |
| Hartung, E | 1 |
| Ludin, HP | 3 |
| De Beukelaar, F | 1 |
| Ahlquist, RP | 1 |
| Bouvenot, G | 1 |
| Escande, M | 1 |
| Jouve, R | 1 |
| Delboy, C | 1 |
| Sehrt, U | 1 |
| Weber, E | 1 |
| Haidri, NH | 1 |
| Gazzillo, FL | 1 |
| Bille, B | 1 |
| Ludvigsson, J | 3 |
| Sanner, G | 1 |
| Holdorff, B | 1 |
| Sinn, M | 1 |
| Roth, G | 1 |
| Pita, E | 1 |
| Higueras, A | 1 |
| Bolaños, J | 1 |
| Pérez, N | 1 |
| Mundo, A | 1 |
| Delwaide, PJ | 1 |
| Congdon, PJ | 1 |
| Otis, SM | 1 |
| Smith, RA | 1 |
| Kroll, AD | 1 |
| Krasny, SE | 1 |
| Seltzer, KA | 1 |
| Dalessio, DJ | 1 |
| Sewing, KF | 1 |
| Prusiner, S | 1 |
| Hicks, M | 1 |
| Hackaday, J | 1 |
| Hardörfer-Brune, E | 1 |
| Kaiser, K | 1 |
| Ekbom, K | 1 |
| Robertson, WC | 1 |
| Schnitzler, ER | 1 |
| Niewodniczy, A | 1 |
| Poźniak-Patewicz, E | 3 |
| Rydzewski, W | 1 |
| Tokola, R | 1 |
| Hokkanen, E | 2 |
| Critchley, EM | 1 |
| Julien, J | 1 |
| Vallat, JM | 1 |
| Lagueny, A | 1 |
| Darriet, D | 1 |
| Borgesen, SE | 4 |
| Robson, RH | 1 |
| Henriksson, KG | 1 |
| Johannsson, V | 1 |
| Lindvall, L | 1 |
| Lundin, H | 1 |
| Nair, KG | 1 |
| Glista, GG | 1 |
| Mellinger, JF | 1 |
| Rooke, ED | 1 |
| Widerøe, TE | 1 |
| Vigander, T | 2 |
| Massiou, H | 2 |
| Bousser, MG | 2 |
| Saxena, PR | 1 |
| Heiligers, JP | 1 |
| Villalón, CM | 1 |
| Ferrari, MD | 1 |
| Gawel, MJ | 1 |
| Kreeft, J | 1 |
| Nelson, RF | 1 |
| Simard, D | 1 |
| Arnott, WS | 1 |
| Zigelman, M | 1 |
| Appel, S | 1 |
| Davidovitch, S | 1 |
| Akselrod, S | 1 |
| Banerjee, M | 1 |
| Findley, L | 1 |
| Weiss, HD | 1 |
| Stern, BJ | 1 |
| Goldberg, J | 1 |
| Formisano, R | 1 |
| Falaschi, P | 1 |
| Cerbo, R | 1 |
| Proietti, A | 1 |
| Catarci, T | 1 |
| D'Urso, R | 1 |
| Roberti, C | 1 |
| Aloise, V | 1 |
| Chiarotti, F | 1 |
| Agnoli, A | 1 |
| Wöber, C | 1 |
| Wöber-Bingöl, C | 1 |
| Koch, G | 1 |
| Dalla Volta, G | 1 |
| Anzola, GP | 1 |
| DiMonda, V | 1 |
| Penzien, DB | 2 |
| Presedo, E | 1 |
| Maissen, CP | 1 |
| Scholz, E | 2 |
| Niederberger, U | 2 |
| Jarman, J | 1 |
| Przyborowska, A | 1 |
| Glover, V | 1 |
| Halket, J | 1 |
| Davies, PT | 1 |
| Sandler, M | 1 |
| Hykin, PG | 1 |
| Gartry, D | 1 |
| Brazier, DJ | 1 |
| Graham, E | 1 |
| Bernard, PA | 2 |
| Bourret, CS | 1 |
| Stenstrom, R | 1 |
| Winther, K | 3 |
| Flodgaard, H | 1 |
| Reidy, M | 1 |
| Savundra, PA | 1 |
| Cleave, N | 1 |
| McAinsh, J | 1 |
| Lütschg, J | 1 |
| Vassella, F | 1 |
| Obana, WG | 1 |
| Cogen, PH | 1 |
| Szymanski, JA | 1 |
| Edwards, MS | 1 |
| Fuller, GN | 1 |
| Guiloff, RJ | 1 |
| Stoica, E | 1 |
| Enulescu, O | 1 |
| Shimell, CJ | 1 |
| Fritz, VU | 1 |
| Levien, SL | 1 |
| Husstedt, IW | 1 |
| Grotemeyer, KH | 1 |
| Schlake, HP | 1 |
| Brune, G | 1 |
| Polo, JM | 1 |
| Berciano, J | 1 |
| Dichgans, J | 1 |
| Jäck, A | 1 |
| Bille, A | 1 |
| Albers, GW | 1 |
| Simon, LT | 1 |
| Hamik, A | 1 |
| Peroutka, SJ | 1 |
| Pradalier, A | 2 |
| Serratrice, G | 1 |
| Collard, M | 1 |
| Hirsch, E | 1 |
| Feve, J | 1 |
| Masson, M | 1 |
| Masson, C | 1 |
| Dry, J | 2 |
| Koulikovsky, G | 1 |
| Nguyen, G | 1 |
| Nowak, TP | 1 |
| James, HE | 1 |
| D'Attoma, G | 1 |
| Nacci, MG | 1 |
| D'Attoma, A | 1 |
| Piccione, M | 1 |
| Lasek, R | 1 |
| Müller, M | 1 |
| Maertens de Noordhout, A | 1 |
| Timsit-Berthier, M | 1 |
| Timsit, M | 1 |
| Schultz, LU | 1 |
| Clifford Rose, F | 1 |
| Katz, B | 1 |
| Knudsen, JB | 1 |
| Schulz, HD | 1 |
| Falkner, R | 1 |
| Taubert, K | 1 |
| Harker, LA | 1 |
| Rassekh, CH | 1 |
| Lücking, CH | 1 |
| Oestreich, W | 1 |
| Schmidt, R | 1 |
| Soyka, D | 1 |
| Stenstrom, RJ | 1 |
| Havanka-Kanniainen, H | 1 |
| Myllylä, VV | 1 |
| Calderón-González, R | 1 |
| Sevilla-Castillo, R | 1 |
| Carrera-Sandoval, JP | 1 |
| Vallejo-Moreno, D | 1 |
| Muszkat, M | 1 |
| Vergani, MI | 1 |
| Torres, DM | 1 |
| Millstein, E | 1 |
| Sudilovsky, A | 1 |
| Elkind, AH | 1 |
| Saper, JR | 2 |
| Stern, MA | 1 |
| Meyer, JH | 1 |
| Hughes, HE | 1 |
| Goldstein, DA | 1 |
| Nadelmann, JW | 1 |
| Phil, M | 1 |
| Johnson, RH | 1 |
| Hornabrook, RW | 1 |
| Lambie, DG | 1 |
| Olerud, B | 1 |
| Gustavsson, CL | 1 |
| Furberg, B | 1 |
| Solomon, GD | 1 |
| Freitag, FG | 1 |
| Mehta, ND | 1 |
| Hassanein, RS | 1 |
| Kodanaz, HA | 1 |
| Preskorn, SH | 1 |
| Mason, J | 1 |
| Giroud, M | 1 |
| Bardwell, A | 1 |
| Trott, JA | 1 |
| Muller, JP | 1 |
| Destée, A | 1 |
| Lozes, G | 1 |
| Pruvo, JP | 1 |
| Jomin, M | 1 |
| Warot, P | 1 |
| Hansotia, P | 1 |
| Mikkelsen, B | 1 |
| Pedersen, KK | 1 |
| Christiansen, LV | 1 |
| MacDonald, JT | 2 |
| Jacome, DE | 1 |
| Risko, M | 1 |
| Kellhammer, U | 1 |
| Pöllmann, W | 1 |
| Olness, K | 1 |
| Uden, DL | 1 |
| Fenichel, GM | 1 |
| Sargent, J | 1 |
| Solbach, P | 1 |
| Baumel, B | 1 |
| Corbett, J | 1 |
| Eisner, L | 1 |
| Jessen, B | 1 |
| Mathew, N | 1 |
| Medina, J | 1 |
| Ahuja, GK | 1 |
| Verma, AK | 1 |
| Gunderson, CH | 1 |
| Contin, M | 1 |
| Durward, WF | 1 |
| Blank, NK | 1 |
| Rieder, MJ | 1 |
| Nielsen, JL | 2 |
| Moller, CE | 2 |
| Lawrence, T | 1 |
| Frankl, WS | 1 |
| Békés, M | 1 |
| Matos, L | 1 |
| Rausch, J | 1 |
| Török, E | 1 |
| Hall, GH | 1 |
| Sharpe, CJ | 1 |
| Weber, RB | 2 |
| Reinmuth, OM | 1 |
| Malvea, BP | 1 |
| Gwon, N | 1 |
| Graham, JR | 1 |
| Rubinowitz, MJ | 1 |
| Wideroe, TE | 1 |
| Baumrucker, JF | 1 |
| Leon-Sotomayor, LA | 1 |
| Castan, R | 1 |
| Aring, CD | 1 |
| Wykes, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of COMT (Catecholamine-O-methyltransferase) Genetic Polymorphisms on Response to Propranolol Therapy in Temporomandibular Disorder[NCT02437383] | Phase 2 | 200 participants (Actual) | Interventional | 2015-08-20 | Completed | ||
| Anti-Calcitonin Gene-Related Peptide (CGRP) Monoclonal Antibody Response After Switching in the Treatment of Migraine[NCT05785988] | 600 participants (Anticipated) | Observational | 2019-11-01 | Recruiting | |||
| Comparison of Efficacy Between Combination of Amitriptyline-propranolol and Pizotifen for Migraine Prophylaxis: A Single-blind Randomized Controlled Trial[NCT06158230] | Phase 2 | 140 participants (Actual) | Interventional | 2023-03-19 | Active, not recruiting | ||
| Efficacy of Memantine Compared With Sodium Valproate in the Prophylactic Treatment of Episodic Migraine.[NCT04698525] | Phase 3 | 33 participants (Actual) | Interventional | 2019-02-15 | Completed | ||
| Targeted Alterations in n-3 and n-6 Fatty Acids for the Management of Mood Variability in the Maintenance Phase of Bipolar Disorder[NCT02272010] | 83 participants (Actual) | Interventional | 2014-10-31 | Completed | |||
| CandeSpartan Study Candesartan Spanish Response-prediction and Tolerability Study Observational Study on Response Predictors and Tolerability of Candesartan in Usual Clinical Practice[NCT04138316] | 85 participants (Actual) | Observational [Patient Registry] | 2020-01-02 | Completed | |||
| Candesartan vs Propranolol for Migraine Prevention: A Double Blind, Placebo Controlled, Double Dummy, Triple Cross-over Study[NCT00884663] | Phase 2/Phase 3 | 72 participants (Actual) | Interventional | 2009-04-30 | Completed | ||
| A Pilot Trial of Galcanezumab for Vestibular Migraine[NCT04417361] | Phase 2 | 50 participants (Anticipated) | Interventional | 2020-09-18 | Recruiting | ||
| Generating Evidence on NonEpileptic, Stereotypical and Intermittent Symptoms (NESIS) in Chronic Subdural Hematomas[NCT04759196] | Phase 4 | 56 participants (Anticipated) | Interventional | 2021-03-01 | Recruiting | ||
| Osteopathic Manipulative Techniques for the Treatment of Chronic Migraine Headaches[NCT04520425] | 11 participants (Actual) | Interventional | 2022-09-08 | Terminated (stopped due to Responsible Party left institution) | |||
| Is Chiropractic Spinal Manipulative Therapy an Efficient Treatment Option for Migraine? A Randomized Controlled Clinical Trial[NCT01741714] | 104 participants (Actual) | Interventional | 2013-02-28 | Completed | |||
| A Randomized, Double-Blind, Parallel-Group, Dose-Response Study to Evaluate the Efficacy and Safety of Two Doses of Topiramate Compared to Placebo and Propranolol in the Prophylaxis of Migraine[NCT00236561] | Phase 3 | 786 participants (Actual) | Interventional | 2001-04-30 | Completed | ||
| The Effect of Blood Pressure on Cerebral Blood Flow During Propofol Anesthesia[NCT03309917] | 30 participants (Actual) | Interventional | 2017-12-27 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Average of 3 repeated measures taken with a 2-minute interval. (NCT02437383)
Timeframe: Visit 1 (study day 0) and Visit 4 (study day 63 +/-7)
| Intervention | mm Hg (Least Squares Mean) |
|---|---|
| Propranolol ER | -3.3 |
| Placebo | 1.0 |
Average of 3 repeated measures taken with a 2-minute interval. (NCT02437383)
Timeframe: Visit 1 (study day 0) and Visit 4 (study day 63 +/-7)
| Intervention | beats per minute (Least Squares Mean) |
|---|---|
| Propranolol ER | -3.9 |
| Placebo | 1.5 |
Measured at TMD exam. A higher value means a better outcome. (NCT02437383)
Timeframe: Visit 1 (study day 0) and Visit 4 (study day 63 +/-7)
| Intervention | mm (Least Squares Mean) |
|---|---|
| Propranolol ER | -0.3 |
| Placebo | -0.8 |
Measured at TMD exam. A higher value means a better outcome. (NCT02437383)
Timeframe: Visit 1 (study day 0) and Visit 4 (study day 63 +/-7)
| Intervention | mm (Least Squares Mean) |
|---|---|
| Propranolol ER | -0.9 |
| Placebo | -1.2 |
Measured at TMD exam. A higher value means a better outcome. (NCT02437383)
Timeframe: Visit 1 (study day 0) and Visit 4 (study day 63 +/-7)
| Intervention | mm (Least Squares Mean) |
|---|---|
| Propranolol ER | 4.5 |
| Placebo | 1.4 |
Pressure values, measured in kilopascals, from up to 5 experimental pressure stimuli, bilaterally applied to the area of lateral epicondyle, will be averaged to obtain a single pressure pain threshold value per anatomical site. (NCT02437383)
Timeframe: Visit 1 (study day 0) and Visit 4 (study day 63 +/-7)
| Intervention | kPa (Least Squares Mean) |
|---|---|
| Propranolol ER | 41.4 |
| Placebo | 22.7 |
Pressure values, measured in kilopascals, from up to 5 experimental pressure stimuli, bilaterally applied to the area of masseter muscle, will be averaged to obtain a single pressure pain threshold value per anatomical site. (NCT02437383)
Timeframe: Visit 1 (study day 0) and Visit 4 (study day 63 +/- 7)
| Intervention | kPa (Least Squares Mean) |
|---|---|
| Propranolol ER | 38.3 |
| Placebo | 29.3 |
Pressure values, measured in kilopascals (kPa), from up to 5 experimental pressure stimuli, bilaterally applied to the area of temporalis muscle, are averaged to obtain a single pressure pain threshold value per anatomical site. The range is 0-500 kPa and a higher value means a better outcome. (NCT02437383)
Timeframe: Visit 1 (study day 0) and Visit 4 (study day 63 +/-7)
| Intervention | kPa (Least Squares Mean) |
|---|---|
| Propranolol ER | 41.8 |
| Placebo | 38.4 |
Pressure values, measured in kilopascals, from up to 5 experimental pressure stimuli, bilaterally applied to the area of temporomandibular joint, will be averaged to obtain a single pressure pain threshold value per anatomical site. (NCT02437383)
Timeframe: Visit 1 (study day 0) and Visit 4 (study day 63 +/-7)
| Intervention | kPa (Least Squares Mean) |
|---|---|
| Propranolol ER | 36.8 |
| Placebo | 25.3 |
Pressure values, measured in kilopascals, from up to 5 experimental pressure stimuli, bilaterally applied to the area of trapezius muscle, will be averaged to obtain a single pressure pain threshold value per anatomical site. (NCT02437383)
Timeframe: Visit 1 (study day 0) and Visit 4 (study day 63 +/-7)
| Intervention | kPa (Least Squares Mean) |
|---|---|
| Propranolol ER | 64.1 |
| Placebo | 63.3 |
Average of 3 repeated measures taken with a 2-minute interval. (NCT02437383)
Timeframe: Visit 1 (study day 0) and Visit 4 (study day 63 +/-7)
| Intervention | mm Hg (Least Squares Mean) |
|---|---|
| Propranolol ER | -3.6 |
| Placebo | 1.3 |
"The HIT-6 contains 6 items and assesses headache-related disability by the frequency of daily activity limitations ranging from never to always. The 6 item scores are summed to yield a global score ranging from 36 to 78. A higher score means a worse outcome." (NCT02437383)
Timeframe: Visit 1 (study day 0) and Visit 4 (study day 63 +/-7)
| Intervention | score on a scale (Least Squares Mean) |
|---|---|
| Propranolol ER | -5.1 |
| Placebo | -3.1 |
"The HADS is a 14-item assessment of anxiety (7 items) and depression (7 items) using the relative frequency of symptoms over the past week, rated on a 4-point scale ranging from 0 = not at all to 3 = very often indeed. Responses are summed to provide separate scores for anxiety and depression with a range from 0 to 21. A higher score means a worse outcome." (NCT02437383)
Timeframe: Visit 1 (study day 0) and Visit 4 (study day 63 +/-7)
| Intervention | score on a scale (Least Squares Mean) |
|---|---|
| Propranolol ER | -1.3 |
| Placebo | -0.7 |
"The HADS is a 14-item assessment of anxiety (7 items) and depression (7 items) using the relative frequency of symptoms over the past week, rated on a 4-point scale ranging from 0 = not at all to 3 = very often indeed. Responses are summed to provide separate scores for anxiety and depression with a range from 0 to 21. A higher score means a worse outcome." (NCT02437383)
Timeframe: Visit 1 (study day 0) and Visit 4 (study day 63 +/-7)
| Intervention | score on a scale (Least Squares Mean) |
|---|---|
| Propranolol ER | -1.0 |
| Placebo | -0.6 |
"The JFLS contains 20 items that measure limitations across mastication, vertical jaw mobility, and verbal/emotional expression rated on a 0-10 scale where 0 = no limitation and 10 = severe limitation. The Global Score is computed as the mean response for all items and ranges from 0 to 10. A higher score means a worse outcome." (NCT02437383)
Timeframe: Visit 1 (study day 0) and Visit 4 (study day 63 +/-7)
| Intervention | score on a scale (Least Squares Mean) |
|---|---|
| Propranolol ER | -1.1 |
| Placebo | -0.8 |
"The PSS assesses the frequency of 14 sources of stress on a scale from 0 = never to 4 = very often. The item scores are summed to yield a global score ranging from 0 to 56. A higher score means a worse outcome." (NCT02437383)
Timeframe: Visit 1 (study day 0) and Visit 4 (study day 63 +/-7)
| Intervention | score on a scale (Least Squares Mean) |
|---|---|
| Propranolol ER | -2.6 |
| Placebo | -1.9 |
The PSQI has 19 items grouped into 7 component scores, each weighted equally on a 0-3 scale, The 7 component scores are summed to yield a global PSQI score, which has a range of 0-21. A higher score means a worse outcome. (NCT02437383)
Timeframe: Visit 1 (study day 0) and Visit 4 (study day 63 +/-7)
| Intervention | score on a scale (Least Squares Mean) |
|---|---|
| Propranolol ER | -0.7 |
| Placebo | -1.0 |
"The SF-12v2 contains 7 questions assessing 8 domains of functioning and well-being rated from: excellent to poor (for general health); yes, limited a lot to no, not limited at all (for functional level); and all of the time to none of the time (for emotional state). These 8 domains can be further summarized into a physical component summary (PCS) and a mental component summary (MCS). The range for each component is 0-100 and a higher score means a better outcome." (NCT02437383)
Timeframe: Visit 1 (study day 0) and Visit 4 (study day 63 +/-7)
| Intervention | score on a scale (Least Squares Mean) |
|---|---|
| Propranolol ER | 3.6 |
| Placebo | 2.8 |
"The SF-12v2 contains 7 questions assessing 8 domains of functioning and well-being rated from: excellent to poor (for general health); yes, limited a lot to no, not limited at all (for functional level); and all of the time to none of the time (for emotional state). These 8 domains can be further summarized into a physical component summary (PCS) and a mental component summary (MCS). summary (MCS). The range for each component is 0-100 and a higher score means a better outcome." (NCT02437383)
Timeframe: Visit 1 (study day 0) and Visit 4 (study day 63 +/-7)
| Intervention | score on a scale (Least Squares Mean) |
|---|---|
| Propranolol ER | 1.2 |
| Placebo | 0.3 |
"The SF-McGill Pain Questionnaire contains 4 affective descriptors rated on a 0-3 scale where 0 = none, 1 = mild, 2 = moderate, and 3 = severe. The item scores are summed to yield a total score ranging from 0 to 12. A higher score means a worse outcome." (NCT02437383)
Timeframe: Visit 1 (study day 0) and Visit 4 (study day 63 +/-7)
| Intervention | score on a scale (Least Squares Mean) |
|---|---|
| Propranolol ER | -2.9 |
| Placebo | -3.1 |
"Self-reported present intensity of facial pain at the moment of assessment scored on a descriptive scale where 1 = no pain' and 6 = excruciating pain. A higher score means worse outcome." (NCT02437383)
Timeframe: Visit 1 (study day 0) and Visit 4 (study day 63 +/-7)
| Intervention | units on a scale (Least Squares Mean) |
|---|---|
| Propranolol ER | -0.9 |
| Placebo | -0.7 |
"The SF-McGill Pain Questionnaire contains 11 sensory descriptors rated on a 0-3 scale where 0 = none, 1 = mild, 2 = moderate, and 3 = severe. The item scores are summed to yield a total score ranging from 0 to 33. A higher score means a worse outcome." (NCT02437383)
Timeframe: Visit 1 (study day 0) and Visit 4 (study day 63 +/-7)
| Intervention | score on a scale (Least Squares Mean) |
|---|---|
| Propranolol ER | -1.9 |
| Placebo | -1.6 |
"Self-reported average facial pain duration for the last week scored on 0-100 percentage scale where percent = percent of waking day you had facial pain. A higher score means a worse outcome." (NCT02437383)
Timeframe: Visit 1 (study day 0) and Visit 4 (study day 63 +/-7)
| Intervention | units on a scale (Least Squares Mean) |
|---|---|
| Propranolol ER | -23.6 |
| Placebo | -21.6 |
"Self-reported average facial pain intensity for the last week scored on 0-100 numerical rating scale where 0 = no pain and 100 = the most intense pain imaginable. A higher score means a worse outcome." (NCT02437383)
Timeframe: Visit 1 (study day 0) and Visit 4 (study day 63 +/-7)
| Intervention | units on a scale (Least Squares Mean) |
|---|---|
| Propranolol ER | -18.2 |
| Placebo | -15.8 |
"Self-reported average fatigue for the last week scored on 0-100 numerical rating scale where 0 = no fatigue and 100 = the greatest imaginable. A higher score means a worse outcome." (NCT02437383)
Timeframe: Visit 1 (study day 0) and Visit 4 (study day 63 +/-7)
| Intervention | units on a scale (Least Squares Mean) |
|---|---|
| Propranolol ER | -12.0 |
| Placebo | -11.4 |
"The SCL-90R Somatization Scale is a 12-item assessment of somatic symptom distress over the past 7 days rated from 0 = not at all to 4 = extremely. The scale score is computed as the mean for all items. The score range is from 0 to 4. A higher score means a worse outcome." (NCT02437383)
Timeframe: Visit 1 (study day 0) and Visit 4 (study day 63 +/-7)
| Intervention | score on a scale (Least Squares Mean) |
|---|---|
| Propranolol ER | -0.2 |
| Placebo | -0.2 |
"Weekly mean pain duration computed as the arithmetic mean of daily pain duration values during the week prior to randomization and prior to each study visit. Daily pain duration is measured on 0-100 percentage scale where percent = percent of waking day you had facial pain as reported in the Daily Symptom Diary. A higher score means a worse outcome." (NCT02437383)
Timeframe: Visit 1 (study day 0) and Visit 4 (study day 63 +/-7)
| Intervention | units on a scale (Least Squares Mean) |
|---|---|
| Propranolol ER | -17.9 |
| Placebo | -16.6 |
"Weekly mean pain index computed as the arithmetic mean of daily pain index values during the week prior to randomization and prior to each study visit. Daily pain index is computed as pain intensity (0-100 numeric rating scale where 0 = no pain and 100 = the most intense pain imaginable) multiplied by pain duration (0-100 percentage scale where percent = percent of waking day you had facial pain) as reported in the Daily Symptom Diary and divided by 100. The pain index range is from 0 to 100. A higher score means a worse outcome." (NCT02437383)
Timeframe: Visit 1 (study day 0) and Visit 4 (study day 63 +/-7)
| Intervention | units on a scale (Least Squares Mean) |
|---|---|
| Propranolol ER | -13.9 |
| Placebo | -12.1 |
"Weekly mean pain intensity computed as the arithmetic mean of daily pain intensity values during the week prior to randomization and prior to each study visit. Daily pain intensity is measured on 0-100 numeric rating scale where 0 = no pain and 100 = the most intense pain imaginable) as reported in the Daily Symptom Diary. A higher score means a worse outcome." (NCT02437383)
Timeframe: Visit 1 (study day 0) and Visit 4 (study day 63 +/-7)
| Intervention | units on a scale (Least Squares Mean) |
|---|---|
| Propranolol ER | -17.1 |
| Placebo | -13.6 |
Temperature values, measured in degrees Celsius, from 4 examiner-applied contact heat stimuli will be averaged to measure the experimental thermal pain threshold (temperature at which pain is first perceived). The range was 32-50 degrees Celsius and a higher value means a better outcome. (NCT02437383)
Timeframe: Visit 1 (study day 0) and Visit 4 (study day 63 +/-7)
| Intervention | degrees Celsius (Least Squares Mean) |
|---|---|
| Propranolol ER | 1.3 |
| Placebo | 0.5 |
Temperature values, measured in degrees Celsius, from 4 examiner-applied contact heat stimuli will be averaged to measure the experimental thermal pain tolerance (temperature at which pain can no longer be tolerated). The range was 32-50 degrees Celsius and a higher value means a better outcome. (NCT02437383)
Timeframe: Visit 1 (study day 0) and Visit 4 (study day 63 +/-7)
| Intervention | degrees Celsius (Least Squares Mean) |
|---|---|
| Propranolol ER | 0.5 |
| Placebo | 0.4 |
"Weekly mean pain index computed as the arithmetic mean of daily pain index values during the week prior to randomization and prior to each study visit. Daily pain index is computed as pain intensity (0-100 numeric rating scale where 0 = no pain and 100 = the most intense pain imaginable) multiplied by pain duration (0-100 percentage scale where percent = percent of waking day you had facial pain) as reported in the Daily Symptom Diary, divided by 100. The pain index range is from 0 to 100. A higher score means a worse outcome. The pain index was stratified per number of catechol-O-methyltransferase (COMT) Low Pain Sensitive (LPS) haplotypes." (NCT02437383)
Timeframe: Visit 1 (study day 0) and Visit 4 (study day 63 +/-7)
| Intervention | units on a scale (Least Squares Mean) | ||
|---|---|---|---|
| 0 LPS haplotypes | 1 LPS haplotype | 2 LPS haplotypes | |
| Placebo | -12.3 | -13.2 | -2.5 |
| Propranolol ER | -14.2 | -12.2 | -15.2 |
"Weekly mean pain index computed as the arithmetic mean of daily pain index values during the week prior to randomization and prior to each study visit. Daily pain index is computed as pain intensity (0-100 numeric rating scale where 0 = no pain and 100 = the most intense pain imaginable) multiplied by pain duration (0-100 percentage scale where percent = percent of waking day you had facial pain) as reported in the Daily Symptom Diary, divided by 100. The pain index range is from 0 to 100. A higher score means a worse outcome. The pain index was stratified per number of catechol-O-methyltransferase (COMT) valine alleles at single nucleotide polymorphism (SNP) rs4680." (NCT02437383)
Timeframe: Visit 1 (study day 0) and Visit 4 (study day 63 +/-7)
| Intervention | units on a scale (Least Squares Mean) | ||
|---|---|---|---|
| 0 valine alleles | 1 valine allele | 2 valine alleles | |
| Placebo | -13.9 | -13.1 | -9.7 |
| Propranolol ER | -14.2 | -13.9 | -14.3 |
To compare the average weight in both arms before and after Valproate and Memantine administration. The weight will be measured in kilograms, and the initial against the final will be compared. (NCT04698525)
Timeframe: Three months
| Intervention | kilograms (Mean) | |
|---|---|---|
| Pre-treatment | Post-treatment | |
| Memantine | 64.44 | 64.19 |
| Valproate Group | 71.77 | 72.13 |
In a double-blind clinical trial, we compared two active drugs (mamantine vs. valproate) three months after initiation, looking for changes in the average number of days of migraine attack presentation per month and comparing the three months before with the three months after treatment administration with two active drugs. (NCT04698525)
Timeframe: Three months before treatment (Pretreatment), three months after initiating treatment (post-treatment)
| Intervention | Migraine days by month. (Mean) | |
|---|---|---|
| Pretreatment | Post-treatment | |
| Memantine | 5.31 | 0.93 |
| Valproate Group | 5.35 | 0.77 |
"The possible reduction in the average on the visual analog scale (0-10) comparing three months before and after three months of the treatment with both drugs. We measured both arms of the study.~0 means without pain. 10 means the worst possible pain in the concept of the patient." (NCT04698525)
Timeframe: Three months previous and three months after the treatment.
| Intervention | Score on a scale (Mean) | |
|---|---|---|
| Pre-treatment | Post-treatment | |
| Memantine | 8.5 | 4.28 |
| Valproate Group | 8.94 | 2.5 |
"To compare the average of Memantine against the group that receives Valproate before and after starting preventive treatment. Using the Migraine Disability Assessment scale (The score is the sum of days missed from work or school, days of housework missed, days of missed non-work activities, and days of work or school plus days of housework in which productivity in the last three months) to compare punctuation changes. The MIDAS score is divided into four degrees, the minimum score is 0 points, and the maximum score is 70. A higher value represents a higher difficulty to carry out a satisfactory lifestyle, and a score higher than 20 points already represents a high limitation to enjoying daily activities:~Grade I (0-5 points): Slight limitations and few patient treatment needs. Grade II (6-10 points): Moderate limitations and treatment needs. Grade III (11-20 points) and IV (21 or more points): Severe and significant punctuation treatment needs." (NCT04698525)
Timeframe: Three months.
| Intervention | score on a scale (Mean) | |
|---|---|---|
| Pre-treatment | Post-treatment | |
| Memantine | 60.87 | 15.57 |
| Valproate Group | 51.92 | 10.53 |
52 reviews available for propranolol and Abdominal Migraine
| Article | Year |
|---|---|
Application of cinnarizine in migraine prevention: A systematic review and meta-analysis.
Topics: Activities of Daily Living; Cinnarizine; Humans; Migraine Disorders; Propranolol; Quality of Life; V | 2022 |
A systematic review and meta-analysis of prophylactic medication of vestibular migraine.
Topics: Dizziness; Humans; Migraine Disorders; Propranolol; Venlafaxine Hydrochloride; Vertigo | 2023 |
The effect of blood pressure lowering medications on the prevention of episodic migraine: A systematic review and meta-analysis.
Topics: Adult; Blood Pressure; Calcium Channel Blockers; Female; Headache; Humans; Male; Migraine Disorders; | 2023 |
Non-CGRP Antagonist/Non-Triptan Options for Migraine Disease Treatment: Clinical Considerations.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Calcium Channel Blockers; Drug-Relat | 2023 |
Network Meta-analysis of Different Treatments for Vestibular Migraine.
Topics: Adult; Female; Humans; Male; Migraine Disorders; Network Meta-Analysis; Propranolol; Valproic Acid; | 2023 |
Acupuncture versus propranolol in migraine prophylaxis: an indirect treatment comparison meta-analysis.
Topics: Acupuncture Therapy; Adrenergic beta-Antagonists; Humans; Migraine Disorders; Outcome Assessment, He | 2020 |
Efficacy, Safety, and Acceptability of Pharmacologic Treatments for Pediatric Migraine Prophylaxis: A Systematic Review and Network Meta-analysis.
Topics: Adolescent; Anticonvulsants; Antidepressive Agents; Antihypertensive Agents; Calcium Channel Blocker | 2020 |
Anti-CGRP monoclonal antibodies for migraine prevention: A systematic review and likelihood to help or harm analysis.
Topics: Antibodies, Monoclonal; Botulinum Toxins, Type A; Calcitonin Gene-Related Peptide; Humans; Migraine | 2021 |
Hints on Diagnosing and Treating Headache.
Topics: Amitriptyline; Analgesics, Non-Narcotic; Antihypertensive Agents; Headache; Humans; Metoprolol; Migr | 2018 |
Beta-blockers for the prevention of headache in adults, a systematic review and meta-analysis.
Topics: Adrenergic beta-Antagonists; Adult; Clinical Trials as Topic; Female; Humans; Male; Migraine Disorde | 2019 |
Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults.
Topics: Adult; Anticonvulsants; Flunarizine; Fructose; Humans; Migraine Disorders; Propranolol; Randomized C | 2013 |
Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults.
Topics: Adult; Anticonvulsants; Flunarizine; Fructose; Humans; Migraine Disorders; Propranolol; Randomized C | 2013 |
Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults.
Topics: Adult; Anticonvulsants; Flunarizine; Fructose; Humans; Migraine Disorders; Propranolol; Randomized C | 2013 |
Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults.
Topics: Adult; Anticonvulsants; Flunarizine; Fructose; Humans; Migraine Disorders; Propranolol; Randomized C | 2013 |
Red flags and comfort signs for ominous secondary headaches.
Topics: Adult; Cooperative Behavior; Diagnosis, Differential; Diagnostic Imaging; Female; Headache Disorders | 2014 |
Prevention of migraine attacks. First-choice treatments.
Topics: Adrenergic beta-Antagonists; Amitriptyline; Analgesics; Anticonvulsants; Antidepressive Agents, Tric | 2015 |
WITHDRAWN: Propranolol for migraine prophylaxis.
Topics: Adrenergic beta-Antagonists; Adult; Calcium Channel Blockers; Humans; Migraine Disorders; Propranolo | 2017 |
Unveiling the relative efficacy, safety and tolerability of prophylactic medications for migraine: pairwise and network-meta analysis.
Topics: Adult; Amines; Amitriptyline; Anticonvulsants; Cyclohexanecarboxylic Acids; Dizziness; Female; Fruct | 2017 |
[Beta blockers in migraine prophylaxis].
Topics: Adrenergic beta-Antagonists; Drug Administration Schedule; Humans; Metoprolol; Migraine Disorders; N | 2009 |
Clinical inquiries. What are the best prophylactic drugs for migraine?
Topics: Adrenergic beta-Antagonists; Amitriptyline; Evidence-Based Medicine; Family Practice; Female; Fructo | 2009 |
Manual therapies for migraine: a systematic review.
Topics: Anticonvulsants; Fructose; Humans; Manipulation, Chiropractic; Massage; Migraine Disorders; Musculos | 2011 |
Manual therapies for migraine: a systematic review.
Topics: Anticonvulsants; Fructose; Humans; Manipulation, Chiropractic; Massage; Migraine Disorders; Musculos | 2011 |
Manual therapies for migraine: a systematic review.
Topics: Anticonvulsants; Fructose; Humans; Manipulation, Chiropractic; Massage; Migraine Disorders; Musculos | 2011 |
Manual therapies for migraine: a systematic review.
Topics: Anticonvulsants; Fructose; Humans; Manipulation, Chiropractic; Massage; Migraine Disorders; Musculos | 2011 |
[Migraine associated with conversion symptoms (Babinski's migraine): evaluation of a series of 43 cases].
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Anti-Anxiety Agents; Anticonvulsants; Antidepr | 2012 |
Clinical inquiries. What medication best prevents migraine in children?
Topics: Amitriptyline; Child; Evidence-Based Medicine; Humans; Migraine Disorders; Propranolol; Valproic Aci | 2003 |
[Current views on migraine and anti-migraine preparations].
Topics: Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Amitriptyline; Analgesics; Analgesics, No | 2003 |
Propranolol for migraine prophylaxis.
Topics: Adrenergic beta-Antagonists; Adult; Calcium Channel Blockers; Humans; Migraine Disorders; Propranolo | 2004 |
Do pizotifen or propranolol reduce the frequency of migraine headache?
Topics: Adolescent; Adrenergic beta-Antagonists; Analgesics, Non-Narcotic; Female; Humans; Migraine Disorder | 2004 |
Clinical advances in the preventive treatment of migraine.
Topics: Amitriptyline; Fructose; Humans; Migraine Disorders; Propranolol; Topiramate; Valproic Acid | 2004 |
Preventive treatment of headaches.
Topics: Acupuncture Therapy; Adrenergic beta-Antagonists; Anticonvulsants; Disease Progression; Fructose; Hu | 2005 |
Migraine headache in children.
Topics: Adolescent; Adrenergic beta-Antagonists; Child; Humans; Migraine Disorders; Propranolol; Serotonin A | 2006 |
beta-Adrenoceptor antagonists: new drugs and new indications.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Glaucoma; Humans; Hypertension; Kinetics; Me | 1981 |
[Use of beta-adrenergic blockers in neurologic and psychiatric clinical practice].
Topics: Adrenergic beta-Antagonists; Alcoholism; Anti-Anxiety Agents; Cardiovascular Diseases; Humans; Hyper | 1981 |
Central actions of beta-adrenoceptor blocking drugs in man.
Topics: Adrenergic beta-Antagonists; Animals; Anxiety Disorders; Behavior, Animal; Brain; Haplorhini; Humans | 1981 |
Beta-adrenoceptor blockade and migraine.
Topics: Adrenergic beta-Antagonists; Atenolol; Brain; Clinical Trials as Topic; Double-Blind Method; Humans; | 1982 |
Prophylaxis of migraine with beta-blockers.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Child; Humans; Migraine Disorders; Propranolol | 1983 |
Psychiatric uses of antiadrenergic and adrenergic blocking drugs.
Topics: Adult; Alcohol Amnestic Disorder; Antipsychotic Agents; Bipolar Disorder; Clinical Trials as Topic; | 1984 |
Comparative review of beta-blocking agents.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Atenolol; Humans; Hypertension; | 1984 |
Management of headaches in childhood.
Topics: Adolescent; Analgesics; Child; Ergot Alkaloids; Headache; Humans; Medical History Taking; Migraine D | 1983 |
An overview of the classification, causes, and treatment of headache.
Topics: Amitriptyline; Analgesics; Antidepressive Agents, Tricyclic; Biofeedback, Psychology; Cerebrovascula | 1984 |
Chronic and recurrent headaches in children and adolescents.
Topics: Adolescent; Analgesics; Angiography; Anticonvulsants; Biofeedback, Psychology; Child; Chronic Diseas | 1984 |
Drug management of adult vascular headaches (migraine and cluster headache): Part II--Prevention and attacks.
Topics: Adult; Amitriptyline; Belladonna Alkaloids; Cluster Headache; Cyproheptadine; Drug Combinations; Erg | 1984 |
Overview of migraine.
Topics: Analgesics; Antidepressive Agents, Tricyclic; Brain Chemistry; Cerebrovascular Circulation; Ergotami | 1982 |
Basic mechanisms of antimigraine drugs.
Topics: Amitriptyline; Animals; Chlorpromazine; Humans; Methysergide; Metoclopramide; Migraine Disorders; Pr | 1982 |
Prophylactic therapy in cyclic vomiting syndrome.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Humans; Male; Migraine Disorders; Periodicity; P | 1995 |
Migraine prophylactic drugs: proof of efficacy, utilization and cost.
Topics: Adult; Amitriptyline; Female; Humans; Male; Migraine Disorders; Propranolol; Verapamil | 1997 |
Profiles of 5-HT 1B/1D agonists in acute migraine with special reference to second generation agents.
Topics: Acute Disease; Animals; Clinical Trials as Topic; Coronary Circulation; Coronary Vasospasm; Drug Des | 1999 |
Abdominal migraine in children with neurofibromatosis type 1: a case series and review of gastrointestinal involvement in NF1.
Topics: Abdominal Pain; Adrenergic beta-Antagonists; Child; Child, Preschool; Female; Humans; Male; MEDLINE; | 2001 |
Abdominal migraine: evidence for existence and treatment options.
Topics: Abdominal Pain; Child; Cyproheptadine; Diet; Humans; Migraine Disorders; Pizotyline; Propranolol; Se | 2002 |
[Treatment of idiopathic headache in childhood - recommendations of the German Migraine and Headache Society (DMKG)].
Topics: Acetaminophen; Adrenergic beta-Antagonists; Age Factors; Analgesics, Non-Narcotic; Biofeedback, Psyc | 2002 |
[Beta-blockers and migraine].
Topics: Adrenergic beta-Antagonists; Atenolol; Clinical Trials as Topic; Dilatation, Pathologic; Evoked Pote | 1992 |
Propranolol in the management of recurrent migraine: a meta-analytic review.
Topics: Adult; Female; Humans; Male; Meta-Analysis as Topic; Migraine Disorders; Prognosis; Propranolol; Rec | 1991 |
Pharmacological versus non-pharmacological prophylaxis of recurrent migraine headache: a meta-analytic review of clinical trials.
Topics: Analysis of Variance; Biofeedback, Psychology; Humans; Meta-Analysis as Topic; Migraine Disorders; O | 1990 |
Current concepts of migraine therapy.
Topics: Calcium Channel Blockers; Ergotamine; Female; Humans; Migraine Disorders; Propranolol | 1988 |
Migraine in children.
Topics: Adolescent; Basilar Artery; Brain Injuries; Cerebrovascular Circulation; Child; Child, Preschool; Co | 1985 |
Beta-adrenergic receptor blocking drugs.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Aortic Aneurysm; Aortic Valve; Arrhythmias | 1973 |
Practical aspects of migraine.
Topics: Analgesics; Cryosurgery; Dilatation; Ergotamine; Female; Humans; Hypoglycemia; Methysergide; Migrain | 1973 |
113 trials available for propranolol and Abdominal Migraine
| Article | Year |
|---|---|
TOP-PRO study: A randomized double-blind controlled trial of topiramate versus propranolol for prevention of chronic migraine.
Topics: Aged; Communicable Disease Control; COVID-19; Double-Blind Method; Fructose; Humans; Migraine Disord | 2022 |
Comparison of the Effect of Propranolol Combination with Cinnarizine and Propranolol in the Prevention of Acute Migraine Attacks.
Topics: Adult; Cinnarizine; Female; Headache; Humans; Male; Migraine Disorders; Propranolol; Quality of Life | 2022 |
Effects of Lasmiditan on Cardiovascular Parameters and Pharmacokinetics in Healthy Subjects Receiving Oral Doses of Propranolol.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aged; Benzamides; Blood Pressure; Cardiova | 2020 |
Effect of comorbid migraine on propranolol efficacy for painful TMD in a randomized controlled trial.
Topics: Adolescent; Adult; Aged; Autonomic Nervous System; Chronic Pain; Double-Blind Method; Facial Pain; F | 2021 |
Topiramate and propranolol for prophylaxis of migraine.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Female; Fructose; Humans; Male; Migraine Disor | 2013 |
Efficacy of amitriptyline, pizotifen and propranolol in the prevention of migraine.
Topics: Acetaminophen; Adolescent; Adult; Amitriptyline; Analgesics, Non-Narcotic; Antiemetics; Child; Dompe | 2013 |
Treatment of comorbid migraine and temporomandibular disorders: a factorial, double-blind, randomized, placebo-controlled study.
Topics: Adrenergic beta-Antagonists; Adult; Analysis of Variance; Comorbidity; Double-Blind Method; Facial P | 2013 |
A comparative study of candesartan versus propranolol for migraine prophylaxis: A randomised, triple-blind, placebo-controlled, double cross-over study.
Topics: Adult; Benzimidazoles; Biphenyl Compounds; Cross-Over Studies; Double-Blind Method; Female; Humans; | 2014 |
A comparative study of candesartan versus propranolol for migraine prophylaxis: A randomised, triple-blind, placebo-controlled, double cross-over study.
Topics: Adult; Benzimidazoles; Biphenyl Compounds; Cross-Over Studies; Double-Blind Method; Female; Humans; | 2014 |
A comparative study of candesartan versus propranolol for migraine prophylaxis: A randomised, triple-blind, placebo-controlled, double cross-over study.
Topics: Adult; Benzimidazoles; Biphenyl Compounds; Cross-Over Studies; Double-Blind Method; Female; Humans; | 2014 |
A comparative study of candesartan versus propranolol for migraine prophylaxis: A randomised, triple-blind, placebo-controlled, double cross-over study.
Topics: Adult; Benzimidazoles; Biphenyl Compounds; Cross-Over Studies; Double-Blind Method; Female; Humans; | 2014 |
N alpha methyl histamine versus propranolol in migraine prophylaxis.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Double-Blind Method; Female; Histamine Ago | 2014 |
Comparison of propranolol and pregabalin for prophylaxis of childhood migraine: a randomised controlled trial.
Topics: Adolescent; Child; Child, Preschool; Female; Humans; Male; Migraine Disorders; Pregabalin; Propranol | 2015 |
Propranolol and venlafaxine for vestibular migraine prophylaxis: A randomized controlled trial.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Depression; Female; Humans; Male; Middl | 2016 |
Effect of a traditional syrup from Citrus medica L. fruit juice on migraine headache: A randomized double blind placebo controlled clinical trial.
Topics: Adrenergic beta-Antagonists; Adult; Citrus; Double-Blind Method; Female; Fruit and Vegetable Juices; | 2016 |
Effect of Prayer on Intensity of Migraine Headache: A Randomized Clinical Trial.
Topics: Adult; Faith Healing; Female; Humans; Iran; Male; Migraine Disorders; Propranolol; Religion; Vasodil | 2017 |
A double-blind, randomized trial of low-dose topiramate vs propranolol in migraine prophylaxis.
Topics: Adrenergic beta-Antagonists; Adult; Anticonvulsants; Brain; Cerebral Arteries; Dose-Response Relatio | 2008 |
Variation in almotriptan effectiveness according to different prophylactic treatments.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Anticonvulsants; Calcium Channel Blockers; Drug Inte | 2009 |
Comparison of treatment effect of sodium valproate, propranolol and tricyclic antidepressants in migraine.
Topics: Anticonvulsants; Antidepressive Agents, Tricyclic; Humans; Migraine Disorders; Propranolol; Treatmen | 2009 |
A double-blind randomized controlled trial of low doses of propranolol, nortriptyline, and the combination of propranolol and nortriptyline for the preventive treatment of migraine.
Topics: Adrenergic beta-Antagonists; Adult; Antidepressive Agents, Tricyclic; Double-Blind Method; Drug Ther | 2009 |
P3MC: a double blind parallel group randomised placebo controlled trial of Propranolol and Pizotifen in preventing migraine in children.
Topics: Adolescent; Adrenergic beta-Antagonists; Child; Child, Preschool; Double-Blind Method; Follow-Up Stu | 2010 |
A randomized trial of propranolol versus sodium valproate for the prophylaxis of migraine in pediatric patients.
Topics: Adolescent; Child; Child, Preschool; Humans; Migraine Disorders; Propranolol; Time Factors; Valproic | 2010 |
Dynamics of changes in self-efficacy and locus of control expectancies in the behavioral and drug treatment of severe migraine.
Topics: Adrenergic beta-Antagonists; Adult; Analysis of Variance; Chi-Square Distribution; Cognitive Behavio | 2010 |
The effect of propranolol on cerebrovascular reactivity to visual stimulation in migraine.
Topics: Adult; Autonomic Nervous System; Cerebrovascular Circulation; Cerebrovascular Disorders; Drug Admini | 2011 |
Randomized, placebo-controlled trial of propranolol added to topiramate in chronic migraine.
Topics: Adolescent; Adult; Aged; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Female; Fo | 2012 |
Efficacy and safety of cinnarizine in the prophylaxis of migraine headaches in children: an open, randomized comparative trial with propranolol.
Topics: Adolescent; Analysis of Variance; Calcium Channel Blockers; Chi-Square Distribution; Child; Cinnariz | 2012 |
Topiramate in migraine prophylaxis--results from a placebo-controlled trial with propranolol as an active control.
Topics: Adult; Anticonvulsants; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; Fema | 2004 |
Topiramate in migraine prophylaxis--results from a placebo-controlled trial with propranolol as an active control.
Topics: Adult; Anticonvulsants; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; Fema | 2004 |
Topiramate in migraine prophylaxis--results from a placebo-controlled trial with propranolol as an active control.
Topics: Adult; Anticonvulsants; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; Fema | 2004 |
Topiramate in migraine prophylaxis--results from a placebo-controlled trial with propranolol as an active control.
Topics: Adult; Anticonvulsants; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; Fema | 2004 |
Effect of low-intensity acenocoumarol on frequency and severity of migraine attacks.
Topics: Acenocoumarol; Adult; Anticoagulants; Cross-Over Studies; Double-Blind Method; Female; Humans; Migra | 2005 |
Sodium Valproate versus Propranolol in paediatric migraine prophylaxis.
Topics: Adolescent; Adrenergic beta-Antagonists; Anticonvulsants; Child; Child, Preschool; Humans; Incidence | 2005 |
Biofeedback assisted diaphragmatic breathing and systematic relaxation versus propranolol in long term prophylaxis of migraine.
Topics: Adolescent; Adult; Biofeedback, Psychology; Female; Humans; Male; Middle Aged; Migraine Disorders; M | 2005 |
Testing the combination beta-blocker plus topiramate in refractory migraine.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Drug Therapy, Combination; Female; Fructose; Humans; Male; | 2007 |
Simvastatin for migraine prevention.
Topics: Adolescent; Adult; Anticholesteremic Agents; Female; Humans; Middle Aged; Migraine Disorders; Propra | 2007 |
Interesting uses of beta blockers. 1. Beta blockers in migraine prevention.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Humans; Migraine Disorders; Propranolol | 1981 |
Beta-adrenoceptor blockade and migraine.
Topics: Adrenergic beta-Antagonists; Atenolol; Brain; Clinical Trials as Topic; Double-Blind Method; Humans; | 1982 |
Psychiatric uses of antiadrenergic and adrenergic blocking drugs.
Topics: Adult; Alcohol Amnestic Disorder; Antipsychotic Agents; Bipolar Disorder; Clinical Trials as Topic; | 1984 |
Beta-blocking drugs in migraine.
Topics: Adrenergic beta-Antagonists; Blood Platelets; Clinical Trials as Topic; Double-Blind Method; Female; | 1984 |
Practical experience of beta-blockade in migraine: a personal view.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Double-Blind Method; Humans; Migraine Disorde | 1984 |
Comparative study of nadolol and propranolol in prophylactic treatment of migraine.
Topics: Adrenergic beta-Antagonists; Adult; Clinical Trials as Topic; Double-Blind Method; Female; Humans; M | 1984 |
Observations on the efficacy of propranolol for the prophylaxis of migraine.
Topics: Adolescent; Adult; Child; Child, Preschool; Clinical Trials as Topic; Female; Humans; Male; Middle A | 1983 |
Prophylactic propranolol in the treatment of headache.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Female; Headache; Humans; Male; Middle Aged; M | 1983 |
Timolol vs propranolol vs placebo in common migraine prophylaxis: a double-blind multicenter trial.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle | 1984 |
Metoprolol and propranolol in migraine prophylaxis: a double-blind multicentre study.
Topics: Adolescent; Adult; Analgesics; Clinical Trials as Topic; Double-Blind Method; Ergotamine; Female; He | 1984 |
Metoprolol and propranolol in the prophylactic treatment of classical and common migraine. A double-blind study.
Topics: Adolescent; Adult; Clinical Trials as Topic; Double-Blind Method; Female; Hemodynamics; Humans; Long | 1984 |
Propanolol ('Inderal') in the treatment of childhood migraine.
Topics: Adolescent; Child; Female; Humans; Male; Migraine Disorders; Nausea; Propranolol; Vomiting | 1984 |
Mechanism of tyramine-induced migraine: similarity with dopamine and interactions with disulfiram and propranolol in migraine patients.
Topics: Adult; Disulfiram; Dopamine; Drug Interactions; Female; Humans; Male; Middle Aged; Migraine Disorder | 1984 |
Steady-state visual evoked potentials during migraine prophylaxis by propranolol and femoxetine.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Evoked Potentials, Visual; Fema | 1984 |
The prophylactic effect of timolol versus propranolol and placebo in common migraine: beta-blockers in migraine.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle | 1982 |
Propranolol in the treatment of migraine.
Topics: Adolescent; Adult; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Methysergide | 1980 |
Comparative trial of Tenormin (atenolol) and Inderal (propranolol) in migraine.
Topics: Adult; Atenolol; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; M | 1980 |
Propranolol (Inderal) and clonidine (Catapressan) in the prophylactic treatment of migraine. A comparative trial.
Topics: Adult; Clinical Trials as Topic; Clonidine; Double-Blind Method; Ergotamine; Female; Humans; Male; M | 1980 |
Comparative trial of Tenormin (atenolol) and Inderal (propranolol) in migraine.
Topics: Adult; Atenolol; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; M | 1980 |
Propranolol and femoxetine, a HT-uptake inhibitor, in migraine prophylaxis. A double-blind crossover study.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Migra | 1981 |
Propranolol's antimigraine action long term for some.
Topics: Clinical Trials as Topic; Humans; Migraine Disorders; Placebos; Propranolol | 1982 |
Enhancing the effectiveness of relaxation-thermal biofeedback training with propranolol hydrochloride.
Topics: Adolescent; Adult; Biofeedback, Psychology; Combined Modality Therapy; Dose-Response Relationship, D | 1995 |
Tolfenamic acid versus propranolol in the prophylactic treatment of migraine.
Topics: Adult; Aged; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Di | 1994 |
Propranolol and amitriptyline in prophylaxis of migraine. Pharmacokinetic and therapeutic effects.
Topics: Adolescent; Adult; Amitriptyline; Blood Pressure; Chromatography, High Pressure Liquid; Discriminant | 1993 |
Comparison of propranolol LA 80 mg and propranolol LA 160 mg in migraine prophylaxis: a placebo controlled study.
Topics: Adolescent; Adult; Aged; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Huma | 1993 |
Health-related quality of life under six months' treatment of migraine--an open clinic-based longitudinal study.
Topics: Adrenergic beta-Antagonists; Adult; Female; Humans; Longitudinal Studies; Male; Medical Records; Mig | 1995 |
Post-marketing cohort study comparing the safety and efficacy of flunarizine and propranolol in the prophylaxis of migraine.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Basal Ganglia Diseases; Belgium; Child; Cohort Studies; | 1996 |
Cyclandelate in the prophylaxis of migraine: a randomized, parallel, double-blind study in comparison with placebo and propranolol. The Study group.
Topics: Adult; Cyclandelate; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Sche | 1996 |
A comparison of divalproex with propranolol and placebo for the prophylaxis of migraine without aura.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Cross-Over Studies; Female; GABA Agents; Human | 1997 |
The way to serotonergic use and abuse in migraine.
Topics: Adult; Behavior; Double-Blind Method; Ergotamine; Female; Humans; Male; Methysergide; Middle Aged; M | 1997 |
Long-term outcome of migraine therapy: predictive value of the frontotemporal nitroglycerin test.
Topics: Adult; Female; Flunarizine; Follow-Up Studies; Humans; Male; Middle Aged; Migraine Disorders; Nitrog | 1998 |
A double blind controlled study of propranolol and cyproheptadine in migraine prophylaxis.
Topics: Adolescent; Adult; Cyproheptadine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; M | 2000 |
Lack of pharmacokinetic interaction between the antimigraine compound, almotriptan, and propranolol in healthy volunteers.
Topics: Adolescent; Adult; Area Under Curve; Cross-Over Studies; Drug Interactions; Female; Half-Life; Human | 2001 |
Cyclandelate in the prophylaxis of migraine: a placebo-controlled study.
Topics: Adolescent; Adult; Cyclandelate; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Di | 2001 |
Alpha-dihydroergocryptine and predictive factors in migraine prophylaxis.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Analysis of Variance; Cross-Over S | 2001 |
Efficacy and tolerability in migraine prophylaxis of flunarizine in reduced doses: a comparison with propranolol 160 mg daily.
Topics: Adolescent; Adult; Aged; Chi-Square Distribution; Confidence Intervals; Double-Blind Method; Drug Ad | 2002 |
Prophylaxis of migraine in children.
Topics: Adolescent; Child; Clinical Trials as Topic; Cyproheptadine; Humans; Migraine Disorders; Pizotyline; | 1977 |
[Propranolol for prophylaxis of migraine (author's transl)].
Topics: Clinical Trials as Topic; Humans; Mathematics; Migraine Disorders; Placebos; Propranolol; Time Facto | 1977 |
Propranolol and migraine. A clinical trial.
Topics: Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Female; Humans; Male; Migraine Disor | 1977 |
[Indications for beta-blockers in neurology].
Topics: Alcoholism; Antiparkinson Agents; Anxiety; Clinical Trials as Topic; Drug Therapy, Combination; Huma | 1978 |
Propranolol for prevention of migraine headaches.
Topics: Clinical Trials as Topic; Drug Administration Schedule; Humans; Migraine Disorders; Propranolol | 1979 |
Double blind study of propranolol for migraine prophylaxis.
Topics: Adult; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Male; Middle Aged; Migraine Disord | 1976 |
[Letter: Preventive treatment of migraine with propranolol].
Topics: Adult; Animals; Cerebrovascular Circulation; Clinical Trials as Topic; Female; Humans; Male; Migrain | 1976 |
Short-term clinical trial of phopranolol in racemic form (Inderal), D-propranolol and placebo in migraine.
Topics: Adolescent; Adult; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Male; Middle Aged; Mig | 1976 |
Treatment of migraine with propranolol.
Topics: Clinical Trials as Topic; Humans; Migraine Disorders; Propranolol | 1976 |
A pilot study of the value of propranolol in migraine.
Topics: Adolescent; Adult; Clinical Trials as Topic; Female; Humans; Male; Migraine Disorders; Pilot Project | 1975 |
[Beta-blockers and migraine].
Topics: Adrenergic beta-Antagonists; Atenolol; Clinical Trials as Topic; Dilatation, Pathologic; Evoked Pote | 1992 |
Comparison of the efficacy and safety of flunarizine to propranolol in the prophylaxis of migraine.
Topics: Adolescent; Adult; Aged; Body Weight; Canada; Double-Blind Method; Female; Flunarizine; Hemodynamics | 1992 |
Propranolol in the treatment of acute migraine attacks.
Topics: Acute Disease; Adult; Aged; Double-Blind Method; Humans; Middle Aged; Migraine Disorders; Propranolo | 1991 |
Nimodipine in migraine: clinical efficacy and endocrinological effects.
Topics: Adult; Female; Growth Hormone; Humans; Luteinizing Hormone; Male; Middle Aged; Migraine Disorders; N | 1991 |
Propranolol in the management of recurrent migraine: a meta-analytic review.
Topics: Adult; Female; Humans; Male; Meta-Analysis as Topic; Migraine Disorders; Prognosis; Propranolol; Rec | 1991 |
[Comparison of the effect of 5-hydroxytryptophan and propranolol in the interval treatment of migraine].
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Aged; Double-Blind Method; Humans; Middle Aged; Migraine Dis | 1991 |
Responders and non-responders to metoprolol, propranolol and nifedipine treatment in migraine prophylaxis: a dose-range study based on time-series analysis.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Dose-Response Relationship, Drug; Female; Follow-Up S | 1991 |
Pharmacological versus non-pharmacological prophylaxis of recurrent migraine headache: a meta-analytic review of clinical trials.
Topics: Analysis of Variance; Biofeedback, Psychology; Humans; Meta-Analysis as Topic; Migraine Disorders; O | 1990 |
Platelet P1, P4-Di (adenosine-51) tetraphosphate (AP4A) in migraine patients before and during beta-adrenoceptor blockade.
Topics: Adenosine Triphosphate; Adult; Blood Platelets; Dinucleoside Phosphates; Female; Humans; Male; Metop | 1990 |
Long-acting propranolol in the prophylaxis of migraine: a comparative study of two doses.
Topics: Adolescent; Adult; Delayed-Action Preparations; Double-Blind Method; Humans; Middle Aged; Migraine D | 1990 |
[The treatment of juvenile migraine using flunarizine or propranolol].
Topics: Adolescent; Child; Child, Preschool; Double-Blind Method; Female; Flunarizine; Humans; Male; Migrain | 1990 |
Propranolol in acute migraine: a controlled study.
Topics: Acute Disease; Adolescent; Adult; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine D | 1990 |
A comparative trial of flunarizine and propranolol in the prevention of migraine.
Topics: Adolescent; Adult; Double-Blind Method; Female; Flunarizine; Humans; Male; Middle Aged; Migraine Dis | 1990 |
Central effects of drugs used in migraine prophylaxis evaluated by visual evoked potentials.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Evoked Potentials, Visual; Female; Humans; Mal | 1989 |
Flunarizine and propranolol in the treatment of migraine.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Flunarizine; Humans; | 1989 |
Nifedipine versus propranolol for the initial prophylaxis of migraine.
Topics: Adult; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Migraine Disorders; Nifedipine; | 1989 |
Long-acting propranolol in migraine prophylaxis: results of a double-blind, placebo-controlled study.
Topics: Adult; Delayed-Action Preparations; Double-Blind Method; Female; Hemodynamics; Humans; Male; Migrain | 1989 |
[A new approach in the treatment of vascular headaches].
Topics: Adolescent; Adult; Child; Clinical Trials as Topic; Dihydroxyphenylalanine; Female; gamma-Aminobutyr | 1985 |
Efficacy of beta-blockers in migraine. A critical review.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Double-Blind Method; Humans; Metoprolol; Migr | 1986 |
The difference between non-selective and beta 1-selective beta-blockers in their effect on platelet function in migraine patients.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adult; Blood Platelets; Cyclic AMP; Double-Blind Meth | 1986 |
Flunarizine vs. propranolol in the prophylaxis of migraine: two double-blind comparative studies in more than 400 patients.
Topics: Adult; Analgesics; Double-Blind Method; Female; Flunarizine; Humans; Male; Middle Aged; Migraine Dis | 1988 |
Comparative efficacy of nadolol and propranolol in the management of migraine.
Topics: Adolescent; Adult; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; | 1987 |
Propranolol in the prophylaxis of migraine.
Topics: Adolescent; Adult; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Migraine Disorders; | 1986 |
Comparison of mefenamic acid and propranolol with placebo in migraine prophylaxis.
Topics: Adult; Aged; Clinical Trials as Topic; Depression; Female; Gastrointestinal Diseases; Humans; Male; | 1986 |
Nadolol and propranolol in migraine management.
Topics: Adolescent; Adult; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; | 1986 |
Long-acting propranolol in the prophylaxis of migraine.
Topics: Clinical Trials as Topic; Delayed-Action Preparations; Humans; Migraine Disorders; Propranolol | 1987 |
Migraine prophylaxis. A comparison of propranolol and amitriptyline.
Topics: Adult; Amitriptyline; Anxiety; Depression; Double-Blind Method; Female; Humans; Male; Middle Aged; M | 1987 |
Prophylactic treatment of migraine with tolfenamic acid, propranolol and placebo.
Topics: Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; | 1986 |
Comparison of self-hypnosis and propranolol in the treatment of juvenile classic migraine.
Topics: Analysis of Variance; Child; Female; Humans; Hypnosis; Male; Migraine Disorders; Propranolol; Prospe | 1987 |
A comparison of naproxen sodium to propranolol hydrochloride and a placebo control for the prophylaxis of migraine headache.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Menstr | 1985 |
Propranolol in prophylaxis of migraine.
Topics: Adolescent; Adult; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Migraine Disorders; | 1985 |
Letter: Propranolol in treatment of migraine in children.
Topics: Adolescent; Body Weight; Child; Humans; Migraine Disorders; Propranolol | 1973 |
Letter: Propranolol in migraine.
Topics: Adult; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Middle Aged; Migraine Disorders; P | 1974 |
The treatment of migraine with propranolol.
Topics: Adult; Clinical Trials as Topic; Evaluation Studies as Topic; Female; Humans; Male; Middle Aged; Mig | 1972 |
Propranolol prophylaxis of migraine.
Topics: Adult; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Migraine Disorders; Placebos; Pr | 1973 |
Propranolol in the treatment of migraine.
Topics: Clinical Trials as Topic; Female; Humans; Male; Migraine Disorders; Placebos; Propranolol; Respirati | 1974 |
Prophylactic treatment of migraine with propranolol. A clinical trial.
Topics: Adolescent; Adult; Age Factors; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Migrain | 1974 |
Propranolol used in prophylaxis of migraine in children.
Topics: Administration, Oral; Drug Evaluation; Female; Humans; Male; Migraine Disorders; Placebos; Propranol | 1974 |
194 other studies available for propranolol and Abdominal Migraine
| Article | Year |
|---|---|
[Migraine Medication].
Topics: Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Headache; Hum | 2023 |
Consensus of the Hellenic Headache Society on the diagnosis and treatment of migraine.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Botulinum Toxins, Type A; Consensus | 2019 |
Analysis of the effectiveness of the prophylaxis of vestibular migraine depending on the diagnostic category and the prescribed drug.
Topics: Acetazolamide; Amitriptyline; Analgesics; Central Nervous System Agents; Flunarizine; Humans; Migrai | 2020 |
Sodium valproate in paediatric migraine.
Topics: Child; Cinnarizine; Double-Blind Method; Humans; Migraine Disorders; Propranolol; Valproic Acid | 2020 |
Pharmacotherapy failure and progression to botulinum toxin injection in vestibular migraine.
Topics: Adult; Aged; Aged, 80 and over; Botulinum Toxins; Dizziness; Female; Humans; Injections; Male; Middl | 2020 |
A novel, injury-free rodent model of vulnerability for assessment of acute and preventive therapies reveals temporal contributions of CGRP-receptor activation in migraine-like pain.
Topics: Animals; Calcitonin Gene-Related Peptide; Disease Models, Animal; Female; Hyperalgesia; Male; Mice; | 2021 |
Propranolol modulation of tetrodotoxin-resistant Na
Topics: Animals; Electric Conductivity; Fluorescent Dyes; Ion Channel Gating; Male; Migraine Disorders; Neur | 2021 |
Comparative effects of traditional Chinese and Western migraine medicines in an animal model of nociceptive trigeminovascular activation.
Topics: Animals; Benzyl Alcohols; Disease Models, Animal; Dura Mater; Glucosides; Levetiracetam; Male; Medic | 2018 |
Soluble guanylyl cyclase is a critical regulator of migraine-associated pain.
Topics: Adrenergic beta-Antagonists; Allosteric Regulation; Animals; Anticonvulsants; Calcitonin Gene-Relate | 2018 |
Preemptive Analgesic and Antioxidative Effect of Curcumin for Experimental Migraine.
Topics: Analgesics; Animals; Antioxidants; Curcumin; Humans; Indomethacin; Malondialdehyde; Migraine Disorde | 2017 |
Propranolol prevents cerebral blood flow changes and pain-related behaviors in migraine model mice.
Topics: Adrenergic beta-Antagonists; Animals; Cerebrovascular Circulation; Cortical Spreading Depression; Di | 2019 |
The Effectiveness of Medical Prophylactic Treatment on Vestibular Migraine and Its Effect on the Quality Of Life.
Topics: Activities of Daily Living; Adrenergic beta-Antagonists; Adult; Aged; Case-Control Studies; Dizzines | 2020 |
Triptan use after starting prophylactic migraine treatment: a retrospective cohort study in a primary care population.
Topics: Adult; Analgesics; Cohort Studies; Female; Humans; Male; Metoprolol; Middle Aged; Migraine Disorders | 2014 |
The Paediatric migraine disability assessment score is a useful tool for evaluating prophylactic migraine treatment.
Topics: Adolescent; Child; Disability Evaluation; Flunarizine; Fructose; Humans; Migraine Disorders; Propran | 2014 |
Vestibular migraine in an otolaryngology clinic: prevalence, associated symptoms, and prophylactic medication effectiveness.
Topics: Adrenergic beta-Antagonists; Adult; Calcium Channel Blockers; Dizziness; Flunarizine; Humans; Male; | 2015 |
[Attacks of abdominal pain can be abdominal migraine].
Topics: Abdominal Pain; Adult; Analgesics; Female; Humans; Migraine Disorders; Propranolol | 2014 |
Cost-effectiveness analysis of interventions for migraine in four low- and middle-income countries.
Topics: Amitriptyline; China; Cost-Benefit Analysis; Fructose; Humans; Income; India; Medication Adherence; | 2015 |
Predictive validity of endpoints used in electrophysiological modelling of migraine in the trigeminovascular system.
Topics: Action Potentials; Animals; Blood Pressure; Disease Models, Animal; Electric Stimulation; Fructose; | 2015 |
The effects of acute and preventive migraine therapies in a mouse model of chronic migraine.
Topics: Acute Disease; Amiloride; Animals; Anticonvulsants; Disease Models, Animal; Drug Evaluation, Preclin | 2016 |
Association of MDR1, CYP2D6, and CYP2C19 gene polymorphisms with prophylactic migraine treatment response.
Topics: Adult; Amitriptyline; ATP Binding Cassette Transporter, Subfamily B; Central Nervous System Agents; | 2016 |
Factors Influencing Response to Pharmacologic Treatment of Migraine in a Pediatric Headache Clinic.
Topics: Adolescent; Age Factors; Amitriptyline; Central Nervous System Agents; Child; Child, Preschool; Coho | 2016 |
A new urticarial rash, diarrhoea and refractory hypotension in a man with a history of migraines.
Topics: Adrenergic beta-Antagonists; Adult; Anaphylaxis; Diagnosis, Differential; Diarrhea; Humans; Hypotens | 2016 |
Using a graphical risk tool to examine willingness to take migraine prophylactic medications.
Topics: Amines; Analgesics; Antidepressive Agents; Antihypertensive Agents; Cross-Sectional Studies; Cyclohe | 2016 |
Persistence with migraine prophylactic treatment and acute migraine medication utilization in the managed care setting.
Topics: Adult; Age Factors; Amitriptyline; Cohort Studies; Databases, Factual; Dose-Response Relationship, D | 2008 |
Short-term outcomes of tension type and migraine headache in children.
Topics: Adolescent; Amitriptyline; Analgesics, Non-Narcotic; Child; Child, Preschool; Female; Humans; Male; | 2008 |
[Effectiveness of chemical, herbal and dietetic migraine prophylactis. An overview of randomized controlled double-blind studies].
Topics: Adrenergic beta-Agonists; Anticonvulsants; Fructose; Humans; Magnesium; Migraine Disorders; Phytothe | 2009 |
Prophylactic drugs and cytokine and leptin levels in children with migraine.
Topics: Adolescent; Amitriptyline; Central Nervous System Agents; Child; Cyproheptadine; Cytokines; Female; | 2009 |
Profile of children with migraine.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Female; Flunarizine; Fructose; Humans; Male; M | 2010 |
Cyclic vomiting syndrome in Taiwanese children.
Topics: Adolescent; Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Age of Onset; Amitriptyline; | 2011 |
[Preventive migraine drugs--now three agents without effect].
Topics: Adrenergic beta-Antagonists; Analgesics; Anticonvulsants; Antidepressive Agents, Tricyclic; Humans; | 2011 |
[Preventive migraine drugs--they are indeed still working].
Topics: Amitriptyline; Analgesics; Antidepressive Agents, Tricyclic; Humans; Migraine Disorders; Propranolol | 2011 |
Botulinum toxin type A for migraine. First, do no harm.
Topics: Botulinum Toxins, Type A; Clinical Protocols; Clinical Trials as Topic; Humans; Migraine Disorders; | 2011 |
Combination therapy for chronic migraine: bad news but not the last word.
Topics: Female; Fructose; Humans; Male; Migraine Disorders; Propranolol; Topiramate | 2012 |
Nonpharmacologic treatment of migraine with low-dose propranolol or amitriptyline.
Topics: Adolescent; Amitriptyline; Child; Child, Preschool; Databases, Factual; Female; Follow-Up Studies; H | 2012 |
Drugs to prevent migraines are underused.
Topics: Adrenergic beta-Antagonists; Anticonvulsants; Fructose; Humans; Migraine Disorders; Preventive Healt | 2012 |
Propranolol-induced relaxation in the rat basilar artery.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Basilar Artery; Calcium; Calcium Chan | 2013 |
Propranolol modulates trigeminovascular responses in thalamic ventroposteromedial nucleus: a role in migraine?
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Electric Stimulation; Glut | 2005 |
[Use of propranolol for migraine prophylaxis].
Topics: Adrenergic beta-Antagonists; Evidence-Based Medicine; Humans; Migraine Disorders; Propranolol; Vasod | 2005 |
Noradrenergic agonists and antagonists influence migration of cortical spreading depression in rat-a possible mechanism of migraine prophylaxis and prevention of postischemic neuronal damage.
Topics: Adrenergic alpha-Agonists; Adrenergic Antagonists; Adrenergic beta-Antagonists; Animals; Blood Press | 2005 |
Bending the rule of monotherapy for migraine prevention?
Topics: Adrenergic beta-Antagonists; Adult; Amitriptyline; Drug Therapy, Combination; Female; Humans; Migrai | 2005 |
Topiramate: new indication. Migraine prevention: best avoided.
Topics: Cost-Benefit Analysis; Double-Blind Method; Fructose; Humans; Migraine Disorders; Neuroprotective Ag | 2006 |
Pharmacological prevention of migraine: to be considered case by case.
Topics: Adrenergic beta-Antagonists; Amitriptyline; Anticonvulsants; Antidepressive Agents; Cost-Benefit Ana | 2006 |
A fatal error.
Topics: Adult; Asthma; Drug Interactions; Drug Labeling; Fatal Outcome; Female; Humans; Medication Errors; M | 2007 |
Antimigraine action of nicotine: theoretical basis and potential clinical application.
Topics: Female; Humans; Middle Aged; Migraine Disorders; Nicotine; Nicotinic Agonists; Propranolol; Vasodila | 2007 |
[Beta blockers today, in the United States].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Aortic Stenosis, Subvalvular; Arrhythmias, Cardiac; Bl | 1982 |
Prevalence of Raynaud's phenomenon in patients with migraine.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Child; Ergotamine; Female; Humans; Male; Middl | 1984 |
Surgical control of chronic migrainous neuralgia by trigeminal ganglio-rhizolysis.
Topics: Adult; Chronic Disease; Ergotamine; Humans; Lidocaine; Lithium; Male; Methysergide; Middle Aged; Mig | 1982 |
Inhibition of peptidase degrading endogenous opioids: a new trend in the management of migraine and correlated "pain diseases".
Topics: Brain; Captopril; Clonidine; Cluster Headache; Endorphins; Humans; Migraine Disorders; Nociceptors; | 1983 |
Migraine. Current concepts of pathogenesis and treatment.
Topics: Adult; Analgesics; Anti-Inflammatory Agents; Cluster Headache; Ergotamine; Female; Humans; Lithium; | 1983 |
Severe peripheral ischaemia during concomitant use of beta blockers and ergot alkaloids.
Topics: Adult; Drug Interactions; Drug Therapy, Combination; Ergotamine; Ergotamines; Female; Humans; Ischem | 1984 |
Plasma concentrations of propranolol and 4-hydroxy-propranolol at steady-state in neurological patients: intersubject and intrasubject correlations with dose.
Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Female; Humans; Individuality; Male; Midd | 1984 |
Serum concentrations of propranolol and migraine prophylaxis.
Topics: Female; Humans; Middle Aged; Migraine Disorders; Propranolol | 1984 |
[Headache in children].
Topics: Brain Neoplasms; Child; Child, Preschool; Contusions; Dihydroergotamine; Ergotamine; Headache; Human | 1984 |
Femoxetine - a new 5-HT uptake inhibitor - and propranolol in the prophylactic treatment of migraine.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Female; Humans; Male; Middle Ag | 1983 |
Propranolol-induced myotonia.
Topics: Adult; Female; Humans; Migraine Disorders; Myotonia; Propranolol | 1984 |
Prophylactic treatment of migraine headache.
Topics: Analgesics; Antidepressive Agents, Tricyclic; Calcium Channel Blockers; Humans; Migraine Disorders; | 1983 |
Fetal demise in a migraine patient on propranolol.
Topics: Female; Fetal Blood; Fetal Death; Humans; Migraine Disorders; Pregnancy; Pregnancy Complications; Pr | 1983 |
How to treat migraine.
Topics: Analgesics; Cluster Headache; Diagnosis, Differential; Ergotamine; Humans; Lithium; Migraine Disorde | 1984 |
Lower extremity ischemia due to combined drug therapy for migraine.
Topics: Drug Therapy, Combination; Ergotamine; Ergotamines; Humans; Ischemia; Leg; Male; Middle Aged; Migrai | 1982 |
Migraine prophylaxis: prognostic significance of clinical factors.
Topics: Adolescent; Adult; Aged; Amitriptyline; Child; Child, Preschool; Female; Humans; Male; Methysergide; | 1983 |
Low-dose propranolol therapy for aborting migraine.
Topics: Adult; Female; Humans; Male; Middle Aged; Migraine Disorders; Propranolol | 1983 |
Propranolol and acetylsalicylic acid in migraine prophylaxis. Double-blind crossover study.
Topics: Adolescent; Adult; Aspirin; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Mid | 1983 |
[Atonic attacks in migraine].
Topics: Adult; Basilar Artery; Cataplexy; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Mig | 1983 |
Pharmacist on call: a new use for propranolol.
Topics: Humans; Migraine Disorders; Propranolol | 1980 |
Drug stop: migraine headache. Current therapy.
Topics: Adolescent; Adult; Child; Clonidine; Diet; Ergot Alkaloids; Female; Humans; Male; Middle Aged; Migra | 1982 |
[Use of propranolol in the treatment of migraine].
Topics: Adult; Female; Humans; Male; Middle Aged; Migraine Disorders; Neck; Propranolol; Vascular Headaches | 1982 |
Prophylaxis of cyclic vomiting with propranolol.
Topics: Child; Female; Humans; Migraine Disorders; Periodicity; Propranolol; Vomiting | 1982 |
An occurrence of complicated migraine during propranolol therapy.
Topics: Cerebral Infarction; Female; Humans; Middle Aged; Migraine Disorders; Propranolol | 1982 |
Ischemic optic neuropathy in migraine.
Topics: Adult; Blindness; Female; Fluorescein Angiography; Humans; Ischemia; Middle Aged; Migraine Disorders | 1982 |
Pediatric cerebellar infarction: case report and review of the literature.
Topics: Adolescent; Cerebellum; Cerebral Infarction; Cerebrospinal Fluid Shunts; Humans; Hydrocephalus; Male | 1982 |
Propranolol-associated visual reduction.
Topics: Adult; Diagnostic Errors; Female; Humans; In Vitro Techniques; Migraine Disorders; Platelet Aggregat | 1982 |
Hemiplegic migraine in childhood: diagnostic and therapeutic aspects.
Topics: Adolescent; Brain; Cerebral Angiography; Electroencephalography; Female; Hemiplegia; Humans; Male; M | 1982 |
Selective and non-selective beta-blockers: are both effective in prophylaxis of migraine? A clinical trial versus methysergide.
Topics: Adolescent; Adult; Female; Humans; Male; Methysergide; Metoprolol; Middle Aged; Migraine Disorders; | 1982 |
Propranolol-induced dyspnea in a nonasthmatic male.
Topics: Adult; Bronchial Spasm; Dyspnea; Humans; Male; Migraine Disorders; Propranolol | 1982 |
Long-term study of propranolol in the treatment of migraine.
Topics: Adult; Female; Humans; Male; Middle Aged; Migraine Disorders; Propranolol; Time Factors | 1982 |
Cerebral infarction and migraine.
Topics: Aspirin; Cerebral Infarction; Humans; Migraine Disorders; Propranolol | 1980 |
Basilar artery migraine in a child: excellent response to propranolol.
Topics: Basilar Artery; Child; Female; Humans; Migraine Disorders; Propranolol | 1981 |
Hemicranial disorder of vasomotor adrenoceptors in migraine and cluster headache.
Topics: Adult; Cerebrovascular Circulation; Cluster Headache; Female; Humans; Male; Middle Aged; Migraine Di | 1980 |
Interval therapy of migraine: long-term results.
Topics: Adolescent; Adult; Aged; Amitriptyline; Cyproheptadine; Ergonovine; Ergotamine; Humans; Middle Aged; | 1980 |
Clinical aspects of familial hemiplegic migraine in two families.
Topics: Adolescent; Adult; Aged; Child; Ergotamine; Female; Hemiplegia; Humans; Male; Middle Aged; Migraine | 1981 |
Treatment of migraine and cluster headache.
Topics: Cluster Headache; Female; Humans; Indoramin; Lithium; Male; Methysergide; Migraine Disorders; Pizoty | 1981 |
[Beta-blockers in the treatment of migraine].
Topics: Humans; Migraine Disorders; Propranolol | 1981 |
Transient bilateral visual reduction and mydriasis after propranolol treatment.
Topics: Adult; Humans; Male; Migraine Disorders; Propranolol; Pupil; Visual Acuity | 1981 |
Extracranial vascular reactivity in migraine and tension headache.
Topics: Adult; Ergotamine; Female; Headache; Humans; Male; Middle Aged; Migraine Disorders; Propranolol; Sca | 1981 |
Considerations on the use of propranolol in complicated migraine.
Topics: Adult; Aphasia; Humans; Male; Migraine Disorders; Propranolol | 1980 |
Newer drug therapies for headache.
Topics: Antidepressive Agents; Aspirin; Bromocriptine; Clonidine; Cluster Headache; Dipyridamole; Headache; | 1980 |
Ocular migraine in a patient with cluster headaches.
Topics: Cluster Headache; Fluorescein Angiography; Humans; Male; Middle Aged; Migraine Disorders; Propranolo | 1980 |
Vasospasm--ubiquitous?
Topics: Angina Pectoris; Angina Pectoris, Variant; Female; Humans; Male; Migraine Disorders; Muscle, Smooth; | 1981 |
Short prophylaxis of migraine.
Topics: Adult; Female; Humans; Male; Migraine Disorders; Propranolol; Time Factors | 1994 |
Propranolol in prophylaxis of migraine.
Topics: Humans; Migraine Disorders; Propranolol | 1994 |
Recurrent migraine and intravenous immune globulin therapy.
Topics: Humans; Immunoglobulins, Intravenous; Male; Middle Aged; Migraine Disorders; Polyradiculoneuropathy; | 1993 |
Weight gain induced by long-term propranolol treatment.
Topics: Adult; Female; Humans; Migraine Disorders; Propranolol; Weight Gain | 1993 |
Effects of antimigraine drugs on retinal spreading depression.
Topics: Acetaminophen; Adrenergic beta-Antagonists; Adrenochrome; Analgesics, Non-Narcotic; Animals; Aspirin | 1996 |
Postmarketing study of the use of flunarizine in vestibular vertigo and in migraine.
Topics: Basal Ganglia Diseases; Betahistine; Cohort Studies; Depression; Female; Flunarizine; Histamine H1 A | 1996 |
Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Benzopyrans; Binding, Competitive; Cell Membrane; C | 1997 |
Migrainous stroke causing thalamic infarction and amnesia during treatment with propranolol.
Topics: Adrenergic beta-Antagonists; Adult; Amnesia; Cerebrovascular Disorders; Female; Humans; Infarction; | 1997 |
[Treatment of migraine attacks and migraine prophylaxis: recommendations of the German Migraine and Headache Society].
Topics: Adult; Analgesics; Antiemetics; Child; Clinical Protocols; Germany; Humans; Metoprolol; Migraine Dis | 1998 |
Noncompliance may render migraine prophylaxis useless, but once-daily regimens are better.
Topics: Administration, Oral; Adolescent; Adult; Aged; Analgesics, Non-Narcotic; Atenolol; Dose-Response Rel | 1998 |
Who reviews the reviewers? Feasibility of using a fictitious manuscript to evaluate peer reviewer performance.
Topics: Confidence Intervals; Confounding Factors, Epidemiologic; Data Interpretation, Statistical; Double-B | 1998 |
New "triptans" and other drugs for migraine.
Topics: Adrenergic beta-Antagonists; Amitriptyline; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive | 1998 |
Abdominal migraine: prophylactic treatment and follow-up.
Topics: Abdominal Pain; Adolescent; Child; Child, Preschool; Cyproheptadine; Female; Gastrointestinal Agents | 1999 |
Contingent negative variation in migraine: effect of beta blocker therapy.
Topics: Adrenergic beta-Antagonists; Adult; Contingent Negative Variation; Diagnosis, Differential; Female; | 1999 |
Increased brain serotonin synthesis in migraine.
Topics: Adrenergic beta-Antagonists; Adult; Brain; Female; Humans; Middle Aged; Migraine Disorders; Nadolol; | 1999 |
Drug information incorrect.
Topics: Canada; Contraindications; Drug Interactions; France; Humans; Migraine Disorders; Oxazoles; Oxazolid | 2000 |
Cortical hyperexcitability is cortical under-inhibition: evidence from a novel functional test of migraine patients.
Topics: Adult; Aged; Analgesics; Cortical Spreading Depression; Female; GABA-A Receptor Agonists; gamma-Amin | 2000 |
[Effect of migraine medications on monocyte chemotaxis] .
Topics: Adult; Analgesics; Aspirin; Chemotaxis, Leukocyte; Dihydroergotamine; Humans; Immune Tolerance; Male | 2000 |
Successful use of propranolol in migraine associated with electroconvulsive therapy.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Depression; Drug Therapy, Combination; Electroconvul | 2001 |
Present state of alpha and beta adrenergic drugs III. Beta blocking agents.
Topics: Adrenergic beta-Antagonists; Anxiety; Arrhythmias, Cardiac; Asthma; Heart Diseases; Humans; Hyperten | 1977 |
[Beta blockaders and general pathology].
Topics: Acebutolol; Adrenergic beta-Antagonists; Asthma; Female; Humans; Hypercalcemia; Hyperglycemia; Hypog | 1977 |
Beta-blockers in migraine prophylaxis.
Topics: Adrenergic beta-Antagonists; Humans; Migraine Disorders; Pindolol; Propranolol | 1978 |
[Basis of pharmaco-therapy. Clinical pharmacology in key words. Finding the dosage].
Topics: Age Factors; Body Weight; Dose-Response Relationship, Drug; Drug Therapy; Extracellular Space; Femal | 1979 |
Newer concepts in management of migraine headaches.
Topics: Acute Disease; Ergotamine; Humans; Methysergide; Migraine Disorders; Propranolol | 1977 |
Migraine in childhood. A review.
Topics: Acute Disease; Age Factors; Anticonvulsants; Child; Child, Preschool; Clonidine; Ergotamines; Female | 1979 |
Vasospasm and vascular headaches: selective vasoconstriction in the carotid vascular system measured by the Doppler ophthalmic method in migraineurs.
Topics: Carotid Arteries; Carotid Artery, Internal; Doppler Effect; Female; Humans; Migraine Disorders; Opht | 1979 |
[Propranolol in migraine].
Topics: Humans; Migraine Disorders; Propranolol | 1979 |
Carotidynia.
Topics: Adult; Aged; Carotid Artery Diseases; Dose-Response Relationship, Drug; Ergonovine; Female; Headache | 1977 |
Cerebral infarction and migraine.
Topics: Aspirin; Cerebral Infarction; Humans; Migraine Disorders; Propranolol | 1979 |
Migraine. Prophylactic drugs.
Topics: Anticonvulsants; Clonidine; Cyproheptadine; Dihydroergotamine; Humans; Methysergide; Migraine Disord | 1977 |
[Propranolol in the therapy of migraine. 44 case of ambulatory therapy with Dociton].
Topics: Ambulatory Care; Female; Humans; Male; Migraine Disorders; Propranolol | 1977 |
[Therapy of migraine and vasomotor cephalea].
Topics: Adrenal Cortex Hormones; Analgesics; Antidepressive Agents; Barbiturates; Clonidine; Ergotamines; Hu | 1978 |
[Improved achievements in the area of headache].
Topics: Cluster Headache; Ergotamine; Headache; Humans; Migraine Disorders; Propranolol | 1978 |
Ophthalmoplegic migraine in infancy.
Topics: Diagnosis, Differential; Female; Humans; Infant; Migraine Disorders; Ophthalmoplegia; Propranolol | 1978 |
[Propranolol in the treatment of migraine and similar headaches].
Topics: Adult; Female; Headache; Humans; Male; Middle Aged; Migraine Disorders; Propranolol; Vascular Headac | 1978 |
Propranolol for acute migraine.
Topics: Acute Disease; Adolescent; Adult; Ergotamine; Female; Humans; Male; Middle Aged; Migraine Disorders; | 1978 |
The diagnosis and management of migraine.
Topics: Acetaminophen; Adult; Analgesics; Antiemetics; Aspirin; Child; Clonidine; Ergotamine; Ergotamines; F | 1978 |
Propranolol for migraine.
Topics: Humans; Migraine Disorders; Propranolol | 1977 |
The phenomenon of "drug dependency" in the treatment of migraine with propranolol.
Topics: Adult; Female; Humans; Migraine Disorders; Propranolol; Substance-Related Disorders | 1977 |
[Drug dependence in propranolol treatment of migraine].
Topics: Female; Humans; Migraine Disorders; Propranolol; Substance-Related Disorders | 1977 |
Recurrent migraine after propranolol.
Topics: Aged; Coronary Disease; Female; Humans; Migraine Disorders; Propranolol | 1977 |
Drugs for migraine.
Topics: Caffeine; Clonidine; Drug Synergism; Ergotamine; Heart Valve Diseases; Humans; Methysergide; Migrain | 1976 |
Propranolol for migraine prophylaxis.
Topics: Adolescent; Adult; Female; Humans; Male; Middle Aged; Migraine Disorders; Propranolol | 1976 |
Familial hemiplegic migraine.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Craniocerebral Trauma; Ergotamines; Female; Hemipl | 1975 |
[Propranolol (Inderal) in migraine].
Topics: Female; Humans; Male; Migraine Disorders; Propranolol; Time Factors | 1975 |
Letter: Uses of propranolol.
Topics: Adult; Aged; Child; Humans; Hypertension; Hyperthyroidism; Hypoglycemia; Male; Middle Aged; Migraine | 1975 |
Propranolol for migraine.
Topics: Humans; Migraine Disorders; Propranolol | 1975 |
Management of migraine.
Topics: Adrenal Cortex Hormones; Aspirin; Clonidine; Humans; Indoles; Migraine Disorders; Propranolol; Sulfo | 1992 |
Effects of tertatolol, a beta-adrenoceptor antagonist with agonist affinity at 5-HT1A receptors, in an animal model of migraine: comparison with propranolol and pindolol.
Topics: Adrenergic beta-Antagonists; Animals; Carotid Arteries; Disease Models, Animal; Hemodynamics; Inject | 1992 |
Propranolol in the prophylaxis of migraine--evaluation by spectral analysis of beat-to-beat heart rate fluctuations.
Topics: Adult; Autonomic Nervous System; Electrocardiography, Ambulatory; Heart Rate; Humans; Migraine Disor | 1992 |
Post-traumatic migraine: chronic migraine precipitated by minor head or neck trauma.
Topics: Adolescent; Adult; Amitriptyline; Chronic Disease; Craniocerebral Trauma; Female; Humans; Male; Midd | 1991 |
Long-term results of migraine prophylaxis with flunarizine and beta-blockers.
Topics: Adult; Aged; Female; Flunarizine; Humans; Male; Metoprolol; Middle Aged; Migraine Disorders; Prognos | 1991 |
The disappearance of the "cold patch" in recovered migraine patients: thermographic findings.
Topics: Adolescent; Adult; Aged; Body Temperature; Child; Female; Humans; Male; Middle Aged; Migraine Disord | 1991 |
Complicated migraine studied by phosphorus magnetic resonance spectroscopy.
Topics: Brain; Humans; Magnetic Resonance Spectroscopy; Migraine Disorders; NADH Dehydrogenase; Propranolol | 1991 |
Minor Symptoms Evaluation (MSE) Profile--a questionnaire for assessment of subjective CNS-related symptoms.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Benzodiazepines; Central Nervous System Diseas | 1990 |
Urinary output of endogenous monoamine oxidase inhibitor and isatin during acute migraine attacks.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Creatinine; Female; Humans; Isatin; M | 1991 |
Bilateral cilio-retinal artery occlusion in classic migraine.
Topics: Adult; Arterial Occlusive Diseases; Ciliary Body; Female; Fluorescein Angiography; Humans; Migraine | 1991 |
Hearing fluctuation during migraine attacks. Activity of propranolol-HCl in rats.
Topics: Animals; Audiometry, Evoked Response; Auditory Threshold; Cerebrovascular Circulation; Epinephrine; | 1991 |
Low doses of propranolol are effective as migraine prophylaxis.
Topics: Humans; Migraine Disorders; Propranolol | 1990 |
Antimigraine treatment for slit ventricle syndrome.
Topics: Adult; Cerebral Ventricles; Cerebral Ventriculography; Cerebrospinal Fluid Shunts; Child, Preschool; | 1990 |
Propranolol corrects the abnormal catecholamine response to light during migraine.
Topics: Adult; Epinephrine; Female; Humans; Male; Migraine Disorders; Norepinephrine; Photic Stimulation; Pr | 1990 |
Abortive versus prophylactic treatment of migraine--a reappraisal.
Topics: Dihydroergotamine; Humans; Migraine Disorders; Propranolol | 1990 |
Paired stimulation and functional change of the sural nerve during beta blocker therapy.
Topics: Adrenergic beta-Antagonists; Adult; Electric Stimulation; Female; Humans; Male; Metoprolol; Middle A | 1989 |
The dose of propranolol for migraine prophylaxis. Efficacy of low doses.
Topics: Adolescent; Adult; Child; Female; Humans; Male; Middle Aged; Migraine Disorders; Propranolol | 1989 |
Migraine headaches in hydrocephalic children: a diagnostic dilemma.
Topics: Cerebrospinal Fluid Shunts; Child; Child, Preschool; Diagnosis, Differential; Female; Humans; Hydroc | 1989 |
[The neuropharmacology of beta adrenolytics].
Topics: Adrenergic beta-Agonists; Animals; Brain; Epilepsy; Humans; Mental Disorders; Migraine Disorders; Ne | 1985 |
The pharmacotherapy of migraine.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Calcium Channel Blockers; Cerebrovascular Circu | 1986 |
[Antimigrainous agents used in maintenance treatment].
Topics: Adrenergic beta-Antagonists; Amitriptyline; Aspirin; Benzoxepins; Calcium Channel Blockers; Cinnariz | 1986 |
Contingent negative variation and efficacy of beta-blocking agents in migraine.
Topics: Adrenergic beta-Antagonists; Adult; Contingent Negative Variation; Electrophysiology; Female; Humans | 1986 |
Beta-adrenergic effects on cerebral circulation.
Topics: Adrenergic beta-Antagonists; Blood-Brain Barrier; Carbon Dioxide; Cerebrovascular Circulation; Human | 1986 |
Beta-adrenoceptor blockade, platelets, and rheologic factors.
Topics: 6-Ketoprostaglandin F1 alpha; Adrenergic beta-Antagonists; Erythrocytes; Fibrinolysis; Humans; Lipop | 1986 |
Platelet activity and selective beta-blockade in migraine prophylaxis.
Topics: Adenosine Diphosphate; Adolescent; Adrenergic beta-Antagonists; Adult; Blood Platelets; Epinephrine; | 1988 |
Migrainous central retinal artery occlusion.
Topics: Adult; Arterial Occlusive Diseases; Humans; Male; Migraine Disorders; Propranolol; Retinal Artery; R | 1986 |
[Progressive relaxation and propranolol in migraine therapy].
Topics: Adult; Combined Modality Therapy; Female; Humans; Male; Migraine Disorders; Propranolol; Relaxation | 1988 |
Episodic vertigo in basilar artery migraine.
Topics: Adolescent; Adult; Aged; Audiometry, Pure-Tone; Basilar Artery; Calcium Channel Blockers; Child; Ele | 1987 |
Onset of action of various migraine prophylactics.
Topics: Adolescent; Adult; Dose-Response Relationship, Drug; Double-Blind Method; Female; Flunarizine; Human | 1988 |
Fluctuating hearing losses in children can be migraine equivalents.
Topics: Animals; Auditory Threshold; Child; Child, Preschool; Deafness; Female; Hearing; Hearing Aids; Human | 1988 |
Long acting propranolol in the prophylaxis of migraine. Comparison of the daily doses of 80 mg and 160 mg.
Topics: Adolescent; Adult; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Migraine Disorder | 1988 |
[Migraine in the child. Clinical study of 212 patients].
Topics: Adolescent; Child; Child, Preschool; Cross-Sectional Studies; Epilepsy; Female; Humans; Infant; Male | 1988 |
[Headache in childhood: diagnosis and therapy. A prospective study of 77 cases].
Topics: Child; Cross-Sectional Studies; Female; Headache; Humans; Male; Migraine Disorders; Pizotyline; Prop | 1988 |
Effectiveness of nadolol in a clinic population of migrainous patients.
Topics: Adolescent; Adult; Antidepressive Agents; Female; Humans; Male; Middle Aged; Migraine Disorders; Mus | 1988 |
Birth defects following maternal exposure to ergotamine, beta blockers, and caffeine.
Topics: Abnormalities, Drug-Induced; Caffeine; Ergotamine; Female; Humans; Infant, Newborn; Migraine Disorde | 1988 |
Somnambulism, migraine and propranolol.
Topics: Adolescent; Adult; Aged; Child; Female; Humans; Male; Middle Aged; Migraine Disorders; Propranolol; | 1987 |
Stroke in migraine as a consequence of propranolol.
Topics: Cerebrovascular Disorders; Humans; Male; Middle Aged; Migraine Disorders; Propranolol | 1987 |
Transient cortical contrast enhancement on CT scan in migraine.
Topics: Female; Humans; Middle Aged; Migraine Disorders; Propranolol; Tomography, X-Ray Computed | 1987 |
Evaluation and treatment of headache. Practical approach to a common symptom.
Topics: Antidepressive Agents, Tricyclic; Chronic Disease; Ergotamine; Headache; Humans; Migraine Disorders; | 1986 |
Childhood migraine. Differential diagnosis and treatment.
Topics: Adolescent; Biofeedback, Psychology; Child; Child, Preschool; Diagnosis, Differential; Headache; Hum | 1986 |
The non-epileptiform basilar artery migraine.
Topics: Adolescent; Basilar Artery; Electroencephalography; Female; Humans; Migraine Disorders; Photic Stimu | 1986 |
Combination headache: practical experience with a combination of a beta-blocker and an antidepressive.
Topics: Adult; Amitriptyline; Cluster Headache; Drug Therapy, Combination; Female; Headache; Humans; Male; M | 1986 |
Management of the migraine patient.
Topics: Amitriptyline; Analgesics; Diagnosis, Differential; Diet; Ergotamine; Humans; Hypnotics and Sedative | 1986 |
Propranolol plasma levels and relief of migraine. Relationship between plasma propranolol and 4-hydroxypropranolol concentrations and clinical effects.
Topics: Adult; Female; Humans; Male; Middle Aged; Migraine Disorders; Propranolol | 1985 |
Propranolol plasma binding and serum lipids during chronic therapy in migraine patients.
Topics: Adult; Blood Proteins; Female; Humans; Lipids; Male; Middle Aged; Migraine Disorders; Propranolol; P | 1985 |
The management of migraine.
Topics: Clonidine; Diet; Dihydroergotamine; Female; Humans; Male; Methysergide; Migraine Disorders; Pizotyli | 1985 |
Letter: Paradoxical response to propranolol in migraine.
Topics: Humans; Male; Middle Aged; Migraine Disorders; Propranolol | 1973 |
Treatment of migraine with propranolol.
Topics: Humans; Male; Middle Aged; Migraine Disorders; Propranolol | 1968 |
Treatment of migraine with propranolol.
Topics: Cardiomyopathies; Humans; Male; Middle Aged; Migraine Disorders; Propranolol | 1968 |
Letter: Propranolol in the treatment of migraine.
Topics: Adult; Cardiomyopathy, Hypertrophic; Clonidine; Female; Humans; Male; Middle Aged; Migraine Disorder | 1974 |
Reflections on the treatment of headache.
Topics: Animals; Aspirin; Cyproheptadine; Ergotamine; Haplorhini; Headache; Hormones; Humans; Methysergide; | 1972 |
Migraine headaches.
Topics: Caffeine; Contraceptives, Oral; Cyproheptadine; Diagnosis, Differential; Diuretics; Drug Combination | 1972 |
Drug interaction--propranolol and cafergot.
Topics: Drug Interactions; Ergot Alkaloids; Humans; Male; Middle Aged; Migraine Disorders; Propranolol; Supp | 1973 |
Cardiac migraine--report of twelve cases.
Topics: Adolescent; Adult; Angina Pectoris; Angiocardiography; Coronary Disease; Diazepam; Diet Therapy; Ele | 1974 |
[Clinical use of propranolol].
Topics: Alcoholism; Angina Pectoris; Aortic Aneurysm; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flut | 1974 |
Emotion-induced headache.
Topics: Ergotamine; Fluphenazine; Headache; Humans; Methysergide; Migraine Disorders; Muscle Contraction; Pa | 1974 |
Migraine. Diagnostic and therapeutic aspects.
Topics: Amitriptyline; Analgesics; Cerebrovascular Circulation; Ergotamine; Humans; Methysergide; Migraine D | 1974 |
Rational treatment of migraine.
Topics: Cyproheptadine; Ergotamine; Humans; Methysergide; Migraine Disorders; Monoamine Oxidase Inhibitors; | 1972 |
The treatment of angina pectoris with coexistent migraine.
Topics: Angina Pectoris; Female; Humans; Male; Middle Aged; Migraine Disorders; Propranolol | 1968 |